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Abstract  
AGE-RELATED GENETIC AND EPIGENETIC CHROMOSOMAL CHANGES: A 
TWIN STUDY 
 
Kimberly Haydu Jones, B.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2009 
 
Director: Colleen Jackson-Cook, Ph.D. 
Department of Pathology 
 
     The primary aims of this study were to examine acquired genetic and epigenetic 
changes that occur in individuals with increasing age and to determine how these changes 
are influenced by genetic/environmental factors.  Acquired genetic changes were 
assessed by determining the frequency and chromosomal contents of spontaneously 
occurring micronuclei in identical and fraternal twins.  A total of 115 individuals (48 twin 
pairs and 19 singletons) were evaluated, ranging in age from 7 to 85 years.  As expected, 
micronuclei frequencies, which are indicative of genomic damage, significantly increased 
with age (p<0.0001, r=0.446).  The majority of micronuclei (32%) contained sex 
chromosomes and the frequency of sex chromosome-bearing micronuclei significantly 
increased with age (p<0.0001). The frequency of autosome-containing micronuclei was 
not significantly influenced by age or gender. However, some autosomes were seen more 
(chromosomes 4, 8, and 9) or less (chromosomes 17 and 22) frequently than expected by 
  
ix
chance (p<0.05).  An evaluation of the numerical contents of the sex chromosome-
containing micronuclei and their corresponding binucleates showed that the majority of 
the binucleates had an abnormal chromosomal complement (either hypodiploid or 
hyperdiploid), with the subset of binucleates having a normal chromosomal complement 
decreasing with age for both the Y chromosome in males and the X chromosome in 
females.  Model fitting, implemented in Mx, showed the variation in the frequency of 
micronuclei to be best explained by either additive genetic and unique environmental 
components, or common and unique environmental factors.  Specific environmental 
exposures and health conditions that were shown to influence micronuclei frequencies, 
included: multivitamins, leafy green vegetables, fruit, vitamin E supplements, arthritis, 
heart disease, allergies, and alcohol. 
      To assess acquired epigenetic changes, global methylation profiles of two identical 
twin pairs were compared and found to differ, indicating that individuals do develop 
alterations in their methylation profiles with age.  Furthermore, the twin pair having a 
significant difference in their micronuclei frequencies and environmental exposures had 
more differences in their methylation pattern compared to the twin pair whose 
micronuclei frequencies and environmental factors did not differ.  Overall, genetic and 
epigenetic changes were shown to occur with age and to be influenced by genetic and 
lifestyle factors. 
  1
 
Chapter 1.  
 
Background and Significance 
 
  It has long been known that constitutional chromosomal abnormalities can have a 
dramatic effect on an individual’s health.  Although acquired chromosomal anomalies 
have been associated with many disease states, such as cancer, little is known about their 
etiology.  In addition to cancer, new evidence is rapidly accumulating to suggest that 
there may also be a link between acquired chromosomal changes and other age-related 
disease states, such as Alzheimer’s disease (Zekanowski and Wojda 2009), rheumatoid 
arthritis (Tascioglu et al., 2005), and osteoarthritis (Castellanos et al. 2004, Dahlen et al., 
2001, Kinne et al., 2001, Mertens et al., 1996, Broberg et al., 1998).  Before the 
significance of this relationship can be understood, more information needs to be 
gathered regarding which specific chromosomal changes occur with age and how these 
changes vary in the normal population.     
The idea that an individual may acquire chromosomal abnormalities with age was 
first proposed in 1961 by Jacobs et al., who first discovered an increase in somatic cell 
chromosome loss with age.  Since then, research studies have led to the conclusion that 
sex chromosomes are most often involved in acquired aneuploidy and that an age effect 
exists, with sex chromosomes being lost with increasing age (Fitzgerald and McEwan, 
1977; Hando et al., 1994; Mukherjee et al., 1995). Interestingly, this age-related loss of 
sex chromosomes has been noted to be most pronounced in females (Fitzgerald and 
McEwan, 1977; Wojda and Witt, 2003).   
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Much less information is available regarding the frequency of autosomal 
abnormalities that are acquired with age, with the existing data leading to conflicting 
conclusions (Mukherjee et al., 1997; Hando et al., 1994).  The results of the few studies 
that have directly evaluated specific autosomal involvment in acquired aneuploidy 
frequencies (using fluorescence in situ hybridization (FISH) techniques on interphase 
cells) have supported the premise of a non-random pattern of autosomal loss.  The non-
random trend of autosomal involvement seems to favor the loss of chromosomes with 
large blocks of heterochromatin (Stacey et al., 1995; Mukherjee et al., 1996; Fauth and 
Zankl 1999; Leach et al., 2004), which may provide valuable insight into the mechanism 
of chromosome loss. 
An alternative method for studying acquired chromosomal changes is through use 
of the cytokinesis-blocked micronucleus (CBMN) assay.  Micronuclei are small round 
bodies, containing whole chromosomes or chromosome fragments left behind during 
anaphase and thus not included into the daughter nuclei (Figure 1).  The frequency of 
micronuclei serves as an indication of DNA damage having been shown to provide 
estimates of chromosomal abnormalities that are comparable to those quantified using 
traditional metaphase analysis for detecting genomic instability (Miller et al., 1998; 
Bonassi et al., 2001).  Similar to the results of FISH studies on interphase cells, much of 
the information collected regarding micronuclei, to date, has shown that the majority of 
micronuclei contain sex chromosomes (Guttenbach et al., 1994; Hando et al., 1994; 
Richard et al., 1994; Zijno et al., 1996; Catalan et al., 1995 and 1998; Norppa and Falck, 
2003). Furthermore, these frequencies have been shown to increase with age (Bolognesi  
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Figure 1. The appearance of a Giemsa stained micronucleus (mn) and corresponding 
binucleate from a lymphocyte culture. 
 
 
 
 
 
 
 
 
 
 
 
 
mn
binucleate 
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et al., 1999; Bonassi et al., 2001), with the most dramatic increase in micronuclei being 
apparent between the ages of 50 and 69, followed by a decrease in micronuclei in 
individuals who live beyond age 69 (Wojda and Witt 2003; Bolognesi et al., 1997).  
Micronuclei frequencies have been shown to be higher in females, but this observation 
has not been consistently seen in all studies (Bonassi et al., 2001).   
While numerous studies have been completed for adults, there is a paucity of 
information available about micronuclei frequency rates in children.  Meta- and pooled 
analyses have been performed to estimate a baseline level of micronuclei frequencies in 
children with no observable gender effect (Neri et al., 2005).  The small amount of 
current information regarding acquired autosomal abnormality frequencies in children 
also suggests a non-random pattern of chromosome involvement in micronuclei (Fauth et 
al., 1998; Norppa and Falck, 2003).  However, researchers have reported mixed results as 
to which autosomes are excluded into micronuclei most frequently and whether or not 
there is an increase in autosome-containing micronuclei with age. Among the autosomes 
that have been suggested to show an over-representation in micronuclei in children are 
chromosomes 1, 9, and 16, which are chromosomes that have large blocks of 
heterochromatin (Sawyer et al. 1995; Stacey et al. 1995; Norppa and Falck, 2003).  
In addition to studies of acquired numerical abnormalities, investigators have also 
evaluated the frequency of acquired structural changes that are present in micronuclei.  
Although the majority of micronuclei in normal, aged individuals contain what appear to 
be intact, structurally normal chromosomes (Wojda and Witt, 2003), this observation has 
not been consistently observed in the micronuclei seen in people having various health 
conditions.  In Parkinson’s disease and systemic lupus erythmatosus, there is an increase 
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in micronuclei containing acentric fragments, yet Alzheimer’s disease patients have been 
shown to have an increase in micronuclei containing whole chromosomes (Migliore et 
al., 1997; 1999a; 1999b).  Although there have been some studies regarding the 
frequencies of micronuclei, information regarding the chromosome-specific contents and 
structure is far from complete.   
Several investigators have reported an increase in micronuclei frequencies in 
patients having cancer when compared to healthy individuals (Tucker and Preston, 1996; 
Duffaud et al., 1997; Venkatachalam et al., 1999; Znoar et al., 2003; Olaharski et al., 
2006; Bonassi et al., 2007).  Micronuclei frequencies have also been found to be 
increased in patients with Alzheimer’s and Parkinson’s disease (Migliore et al., 1997; 
Migliore et al., 2002).  The cause of this increase in peripheral blood micronuclei 
frequencies remains controversial, and seems to vary with the specific disease. For 
example, the increase seen in Parkinson’s patients has been speculated to arise from the 
“endogenously produced or exogenous toxins capable of damaging, via oxidative 
mechanisms, nigral dopaminergic neurons as their principal target” (Migliore et al., 
2002). Alternatively, the increased frequency of micronuclei in Alzheimer’s patients has 
been linked to a defect in microtubule assembly (Migliore et al., 1997).  In cancer, one 
theory is that the correlation of lymphocyte micronuclei frequencies reflects genomic 
damage that also contributes to cancer initiating events in other tissues (Bonassi et al., 
2007).     
Some researchers have reported that environmental factors influence the 
frequency of acquired chromosomal abnormalities.  The factors that have been shown to 
influence micronuclei frequencies include diet, hormone supplementation, and tobacco 
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usage, with the association of tobacco usage and micronuclei frequencies varying from 
no effect to increased frequencies (reviewed in Battershill et al., 2008; Fenech 1993; 
Schneider et al., 2001; Bonassi et al., 2001).   
Differences in micronuclei frequencies observed between individuals have also 
been reported, with genetic influences being postulated to impact the frequency of 
acquired chromosomal abnormalities.  Of particular interest are the results of a study 
reported by Bonassi and Fenech (2004), who found that chronic in vitro alcohol treatment 
induced an increase in micronuclei frequencies in cell lines having a BRCA1 gene 
mutation.  Researchers have also consistently found an increased frequency of 
micronuclei with alcohol use in individuals having genetic variants in the alcohol 
metabolizing enzyme, alcohol dehydrogenase (Ishikawa et al., 2006; Kim et al., 2005).  
The exact role genetics and/or environment play in acquired chromosomal abnormalities 
is still largely unknown.   
Twin studies are a useful way to determine the role that environment and genetics 
play in determining observed phenotypic variations.  Phenotypic differences in 
monozygotic twins are usually treated as evidence of an environmental influence.   To 
date, very few studies have examined the frequency of acquired chromosomal 
abnormalities in twins.  One such study, by Jarvik and Kato (1970), found a genetic 
contribution to aneuploidy in 61 adult twins studied.  However, this investigation was 
performed using metaphase cells, prior to the advent of chromosome banding technology.  
Thus, the completion of a twin study analyzing the role of genetics and/or environment 
on acquired chromosomal abnormalities, using today’s technology, is long overdue.            
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While acquired chromosomal changes in DNA (aneuploidy) have been noted for 
almost 50 years, it was only recently recognized that chromatin has the potential to 
undergo epigenetic changes with advancing age.  Epigenetic modifications, such as DNA 
methylation, play an important role in the control of gene expression and chromosome 
structure (Frigola et al. 2002; Peaston and Whitelaw, 2006).  Simplistically, methylation 
typically prevents gene expression, while loss of methylation allows transcription.  Some 
researchers report that methylation increases with age, while others report an overall 
decrease in methylation with age (Golbus et al., 1990; Cooney, 1993; Vertino et al., 
1994; Toyota et al., 1999; Geigl et al., 2004; Clayton et al., 2005; Wojdacz and Hansen, 
2006). The cause of these changes in methylation patterns with age is unknown.  Some 
believe it is a function of diet and environment, while others believe it to be a random 
process (Cooney, 1993; Fenech 2002; Jaenisch et al., 2003; Bjornsson et al., 2004; 
Peaston and Whitelaw, 2006).  It has been hypothesized that as humans age, they 
accumulate epigenetic and/or chromosomal changes over time (Wong et al, 2005; 
Petronis, 2006). Once multiple changes are acquired, they may result in the development 
of an age-related complex disease.  In fact, many cancer cells have been shown to 
develop epigenetic changes (reviewed by Iacobuzio-Donahue, 2009).  Some scientists 
have argued that epigenetic changes are more clearly associated with tumor progression 
than specific mutations (Feinberg and Tycko, 2004). However, the role these changes 
play in the genesis of disease has not been fully resolved. The possible randomness and 
unpredictable nature of these changes in DNA methylation has been suggested as an 
explanation for the observations in monozygotic twins, who have no evident differences 
in environmental exposure, being discordant for certain diseases (schizophrenia at 50% 
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discordance for MZ twins, 70% for rheumatoid arthritis, and 80% for breast cancer) 
(King et al., 1992; Petronis, 2001; Singh et al., 2002).  Studies showing no difference in 
the frequency of phenotypic discordance between MZ twins raised apart when compared 
to MZ twins raised together suggest that this discordance reflects a mechanism other than 
environment (Wong et al. 2005).  Large amounts of epigenetic changes can accumulate 
over thousands of mitotic divisions in cells from two genetically identical individuals 
(Petronis 2001).  In their paradigm shifting study, Fraga et al. (2005) found that patterns 
of epigenetic modifications in monozygotic twin pairs diverge as they become older, 
which has been described as epigenetic drift (Martin, 2005).  These alterations in an 
individual’s epigenetic profile appear to be much more prevalent than DNA mutations 
(Bennett-Baker, 2003).  In contrast to the study by Fraga et al. (2005), which examined 
global epigenetic changes, studies by Petronis et al. (2003) and Agrelo et al. (2006) 
examined local epigenetic changes of single, disease-related genes.  In these cases, it was 
discovered that epigenetic changes in these gene regions appear to be linked to the 
disease state.  Increasing numbers of autosomal genes were affected by methylation 
changes that occur during aging (Wojdacz and Hansen, 2006).  Methylation specific 
arrays have also been used to evaluate changes in methylation with age. Using this 
technology, specific genes that seem to vary in methylation status with age and gender 
have been identified and include activin A receptor type I, interleukin 6, caspase 
recruitment domain-containing protein 15, platelet-derived growth factor receptor alpha, 
nuclear factor kappa-B subunit 1, and ETS-domain protein (Boks et al., 2009).   
Since epigenetic mechanisms play a key role in establishing and maintaining 
chromosomal structure, specifically heterochromatin and euchromatin, it is possible that 
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epigenetic changes could be an underlying mechanism causing the structural and 
numerical chromosomal abnormalities associated with aging.  Methylation differences 
that occur with age have the potential to contribute to somatic mutations, altering normal 
chromosome structure (Singh et al., 2002; Jones and Takai, 2001).  Chromosomal 
translocations have been found to occur in hypomethylated regions (Richardson 2002).   
Fauth et al. (1998) found that treatment with the drug 5-azacytidine, which induces 
hypomethylation, increased the frequencies of micronuclei containing the chromosomes 
1, 9, and 16, which have large blocks of heterochromatin.  They concluded that 
undermethylation of heterochromatin may be associated with loss of specific 
chromosomes.   
Thus, while much has been learned regarding the occurrence of acquired 
chromosomal abnormalities that arise in humans, many questions remain.  Are 
individual’s genetically predetermined to acquire these chromosomal changes or are these 
chromosomal changes more strongly affected by an individual’s environment? Are these 
changes acquired randomly or do commonalities exist between individuals?  The primary 
aims of this study were to better characterize the chromosome-specific frequencies of 
acquired chromosomal abnormalities as assessed through the CBMN assay, and to 
determine the extent to which the variation in the frequency of micronuclei was 
determined by genetics and/or environment.  A secondary aim was to determine if global 
methylation patterns varied between twin pairs and with age. These aims were achieved 
by testing the following hypotheses: 
1. Micronuclei frequencies increase with age. 
2. Micronuclei frequencies are influenced by both genetic and environmental 
factors. 
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3. There is a nonrandom pattern of chromosomal exclusion into micronuclei, 
with this pattern being age-related. 
4. Methylation patterns change with increasing age. 
5. The acquisition of changes in the pattern of methylation within an 
individual are positively correlated with their frequency of micronuclei. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  11
 
Chapter 2. 
 
Genetic and environmental factors contributing to spontaneous micronuclei 
frequencies in children and adults: A twin study. 
 
 Introduction 
 
Acquired chromosomal abnormalities were first reported to occur in human 
somatic cells in 1961 (Jacobs et al.).  Since that initial discovery, the majority of 
investigations of acquired chromosomal changes have centered on their association with 
particular types of neoplasia.  Sandberg (1990) reported that approximately 85% of the 
affected tissues from patients with cancer have acquired chromosomal changes.  In 
addition to cancer, new evidence is rapidly accumulating to suggest that there may also 
be a link between acquired chromosomal changes and other age-related disease states, 
such as Alzheimer’s disease (Zekanowski and Wojda 2009), rheumatoid arthritis 
(Tascioglu et al., 2005), and osteoarthritis (Castellanos et al. 2004; Dahlen et al., 2001; 
Kinne et al., 2001; Mertens et al., 1996; Broberg et al., 1998). However, little is known 
about the frequency or types of acquired chromosomal changes that spontaneously arise 
in healthy humans, especially in children. 
One approach for understanding the etiology of acquired chromosomal changes 
has been to delineate their frequency of occurrence and to see if consistent patterns 
emerge that might suggest a causative factor(s). The “gold standard” for scoring acquired 
chromosomal abnormalities has been the evaluation of metaphase chromosomes. While 
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this technique allows for full characterization of all cytogenetic findings present, it is 
limited in that it is: (1) labor intensive, thereby reducing the number of observations that 
can be collected; and (2) at risk for producing “artifactual” anomalies as a result of the 
necessary cell culture, harvesting, and slide making procedures.  The cytokinesis-block 
micronucleus (CBMN) assay has been used as an alternative approach to estimate the 
frequency of acquired chromosomal changes. This CBMN assay provides information 
regarding the previous interphase/mitotic division of a somatic cell prior to the presence 
of selective pressure on the resultant daughter cells.  Given that this assay allows for an 
assessment of a large number of cells (1000 or more) and is less labor intensive than 
conventional cytogenetic studies to perform, it has potential for use as a high throughput 
assay.   
      A micronucleus is defined as a small structure that is juxtaposed to the main 
daughter nuclei following mitosis. Micronuclei are thought to contain chromatin (from 
one or more chromosomes) that was not incorporated into the daughter nuclei 
(“lagging” or “lost”) following cell division (Fenech and Morley, 1985).  Micronuclei 
frequencies have been shown to increase with both age and DNA damage, providing 
data that closely parallels that of metaphase chromosomal analyses (Miller et al., 1998; 
Bonassi et al., 2001). Thus, the assessment of micronuclei frequencies has become a 
very attractive biosurveillance tool for quantifying genomic damage associated with 
environmental insults and occupational exposures, as well dietary and lifestyle habits 
(Battershill et al., 2008).  As anticipated from the above noted observations regarding 
chromosomal changes and age-related conditions, researchers have also reported 
micronuclei frequencies to be increased in individuals with different health conditions, 
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such as cancer, Alzheimer’s disease, and Parkinson’s disease (Tucker and Preston, 
1996; Duffaud et al., 1997; Venkatachalam et al., 1999; Znoar et al., 2003; Olaharski et 
al., 2006; Migliore et al. 1997; Migliore et al. 2002).  Given the potential use of this 
assay for recognizing individuals who may have an increased risk for developing health 
problems, it is important to understand the factors that influence alterations in 
micronuclei frequencies. In particular, it is not known if most of the variation observed 
for micronuclei frequencies reflects environmental exposures, a predisposition based on 
one’s genetic make-up, or an interaction between heritable genetic and environmental 
factors.      
One of the most robust methods for identifying sources of variation in humans is 
to study specific traits in twins. Thus, the primary aim of this study was to measure the 
frequency of spontaneously occurring micronuclei in twins of differing ages and to 
determine the extent to which the variation in the frequency of micronuclei was 
determined by genetics and/or environment.  
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Materials and Methods 
 
Sample Ascertainment 
A total of 48 twin pairs and 19 singletons, whose co-twin did not complete the 
sample collection process, were studied.   The twins were ascertained through the Mid-
Atlantic Twin Registry (MATR). Of the 115 participants, 52 were males and 63 were 
females.   The only study inclusion criterion was that the twins be of the same gender (to 
eliminate confounding effects in data interpretation that might arise from potential gender 
differences). After providing their informed consent (VCU IRB protocol #179), the 
participants submitted blood samples and a completed health history questionnaire.  
Blood samples were collected by the participants’ health care providers. Following their 
collection, the samples were shipped to our laboratory via an overnight delivery carrier.   
 
DNA Isolation and Zygosity Determination 
Genomic DNA was isolated from whole blood using the Puregene DNA Isolation 
Kit (Qiagen).  Zygosity was determined using 13 highly polymorphic short tandem repeat 
sequences (AmpFlSTR Profiler Plus and Cofiler kits, Applied Biosystems, Foster City, 
CA) according to standard procedures. Twins were classified as monozygotic if the 
marker data for the co-twins matched at all 13 loci. Co-twins having marker differences 
were identified as a dizygotic pair.  
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Cell Culture 
  Lymphocytes were isolated using Histopaque-1077 (Sigma) and lymphocyte 
cultures were established according to the protocol of Fenech (1993).  Briefly, 
cytochalasin B (Sigma, 14930-92-2) was added to the cells 44 hours after culture 
initiation at a concentration of 3.0 μg/ml.  At 72 hours, binucleate interphase cells were 
harvested using standard techniques, which included a 10-minute incubation in hypotonic 
solution (0.075 M KCl), and serial fixation (three times using a 3:1 methanol: acetic acid 
solution). Slides were made following standard procedures (Leach and Jackson-Cook, 
2001).  
 
Micronuclei Analysis 
The prepared slides were stained for 4 minutes in a 4% Harleco Giemsa solution. 
Micronuclei frequencies were determined by replicate scoring (2 times per slide) of the 
number of micronuclei observed per 1000 cytochalasin-B blocked binucleates, following 
the criteria established by Fenech et al. (2003). The frequency of micronuclei was 
calculated by averaging the values obtained from the 2 replicate scores (2000 total 
binucleates counted).  
 
Statistical Analysis 
Non-parametric Spearman’s correlation coefficients were calculated for the 
association comparisons using either the JMP 8 (Version 8.0.1) or R (Version 2.9.1) 
statistical analysis packages. The impact of additive genetic (A), common environmental 
(C), and/or unique environmental (E) factors on micronuclei frequencies was evaluated 
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using an ACE model fitting approach (Neale and Cardon, 1992) (Figure 2).  This 
analysis, which was implemented in Mx, allowed for an evaluation of the fit of full 
(ACE) and reduced (AE, AC, or CE) models with log-likelihood ratio tests.  A univariate 
regression analysis, with and without correction for age, was used to assess the effects of 
health history, lifestyle, and medication usage on micronuclei frequencies.  When 
indicated by the univariate analysis, general linear modeling was used to assess the age-
corrected variation in micronuclei frequencies seen for other potential predictive factors 
(such as alcohol use, calcium or multivitamin consumption). In order to limit type I 
errors, an alpha level of p<0.05 was used for all statistical tests. 
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E C E C A A 
Twin 1 Twin 2 
Figure 2. Path diagram illustrating the potential sources of variance on acquired 
chromosomal abnormalities for MZ and DZ twin pairs, additive genetics (A), 
common environmental (C), and unique environmental (E).  The MZ additive genetic 
correlation is 1.  The DZ additive genetic correlation is ½. The common environmental 
correlation is equal to 1 for both DZ and MZ twins.       
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Results 
 
Sample Distribution 
The ages of the study participants ranged from 7 to 85 years, and included 52 
male and 63 female participants (Table 1).  The average age of the male and female 
participants was 47.5 and 41.3, respectively.  Of the 48 complete twin pairs collected, 33 
were determined to be monozygotic, with 15 being dizygotic. The majority of samples 
were submitted from individuals living in the Mid-Atlantic region (Virginia and North 
Carolina were most common). However, samples were collected from individuals 
residing in locales throughout the United States (including California, Colorado, Florida, 
Indiana, Michigan, Missouri, North Dakota, Pennsylvania, South Carolina, Texas, 
Tennessee, and Washington).  
 
Micronuclei frequencies  
No significant difference in micronuclei frequencies was observed between males 
(1.39% ± 0.11% [mean ± standard error]) and females (1.22% ± 0.10%) (p=0.87), 
regardless of their age (p=0.254) (Figure 3).  As a result, the data from males and females 
were pooled for all other statistical comparisons.  A significant positive correlation was 
detected between micronuclei frequency and age (p<0.0001, r=0.446), as shown in 
Figures 3 and 4.  Interestingly, the highest frequency of micronuclei was observed for the 
twins who were 60 to 69 years of age, with the lowest frequencies being noted for the 
twins who were 19 years of age or younger.   The variation in micronuclei frequencies 
observed for the children (ages 7 to 18) ranged from 0.1% to 2%, with variation in  
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Table 1. Sample distribution and micronuclei frequencies by age group 
 
 
Age 
Group 
 
 
 
Males 
 
 
 
Females 
 
 
 
Total 
MN 
Frequency per 
1000 
binucleates 
(mean ± s.e.) 
 
 
MZ 
pairs 
 
 
DZ 
pairs 
 
 
Singletons
7-9 4 2 6 5.6+1.1 3 0 0 
10-19 6 18 24 7.6+ 0.9 7 5 0 
20-29 1 5 6 14.2+3.7 2 0 2 
30-39 7 2 9 12.8+1.4 3 0 3 
40-49 6 13 19 12.9+1.3  6 1 5 
50-59 6 6 12 11.3+1.3 2 2 4 
60-69 11 9 20 22.5+2.5 5 3 4 
70-79 9 6 15 13.3+1.7 3 4 1 
80+ 2 2 4 14.3+1.1 2 0 0 
Total 52 63 115 13.0 + 0.8  33 15 19 
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Figure 3. Mean micronuclei frequency by age decade and gender. The 
micronuclei frequency is presented as the number of micronuclei scored per 1000 
binucleates + standard error.  The micronuclei values for males (black histograms) 
and females (grey histograms) are shown. 
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Figure 4.  Correlation of micronuclei frequency with age. Micronuclei 
frequencies (Y axis) are presented as the mean number of micronuclei per 
1000 binucleates. The spontaneous frequency of micronuclei, plotted in 
relation to the 115 study participants’ age (X axis), showed a significant 
positive correlation (r=0.446).  
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younger adults (19 to 49) and middle-aged to older twins (50 or older) ranging from 0.3% 
to 3% and, 0.4% to 4.5%, respectively.   
 
Micronuclei frequencies and genetics 
  The correlation coefficient for micronuclei frequencies between monozygotic 
twins (who share all of their genes) was 0.5 (p=0.003) compared to 0.42 (p=0.118) for the 
dizygotic twins (who share half of their genes). Given that the correlation between 
identical twins was only 0.5, one can infer that there are unique environmental factors 
influencing the frequency of micronuclei. However, the ACE model fitting analysis 
showed that unique environmental effects alone (E) provided a significantly poor fit to 
the data (p<0.0004). While none of the models evaluated showed a strong fit to the data, 
the best fitting models were those that included influences from both additive genetic and 
unique environment (AE), or both common and unique environmental effects (CE) 
(Table 2). 
 
Micronuclei frequencies and health history questionnaire information 
  Given that unique environmental effects, in conjunction with either additive 
genetic and/or common genetic effects, appear to contribute to the observed variation in 
micronuclei frequencies, we assessed the effect of various unique environmental and 
health components on micronuclei frequencies (Tables 3 and 4).   An initial univariate 
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Table 2. Mx ACE model fitting. 
 
Model -2LnL k AIC chi2 df p-value 
ACE 285.099 4 81.099 2.454 3 0.4837 
CE 285.099 3 79.099 0 1 1.000 
AE 286.794 3 80.794 1.695 1 0.1929 
E 300.657 2 92.697 15.558 2 0.0004 
k= parameters 
AIC= Akaike's Information Criterion 
Chi2= Chi-square value 
Df= Degrees of freedom 
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analysis showed that age had the most significant influence on micronuclei frequencies 
(p<0.00000043).  Therefore, an age-corrected univariate assay was performed to evaluate 
the effect of other potential influences. The age-corrected analysis showed a significantly 
increased frequency of micronuclei to be associated with a history of allergies (Table 3) 
and with the consumption of vitamin E supplements (Table 4), with a borderline 
significance value being observed for body mass index (BMI) (which led to a tendency 
for increased micronuclei frequencies). In contrast, a significantly decreased frequency of 
micronuclei was associated with eating fruit (at least 5 days per week); green vegetables 
(at least 5 days per week); or folate-supplemented bread (at least 5 days per week) (Table 
4).  
Surprisingly, a significantly decreased frequency of micronuclei was also noted 
for people reporting a history of heart disease and arthritis (Table 3). Given that most of 
the individuals who reported having heart disease and arthritis also reported taking 
medication to treat these conditions, the effect that these medications might have on 
micronuclei frequencies was evaluated. Medication groups used by less than 4 
individuals were not analyzed due to the small sample size.   Individuals who reported 
taking angiotensin converting enzyme (ACE) inhibitors for treatment of their heart 
disease had a significantly lower frequency of micronuclei compared to individuals who  
did not report taking these medications (Table 5). In contrast, diuretics usage was 
associated with a significantly higher frequency of micronuclei (Table 5).   
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Table 3. Age-corrected univariate regression analysis of association of 
health history factors with lymphocyte micronuclei frequencies.  
Health History Predictor N MN 
Frequency/1000 
binucleates 
(mean ± s.e.) 
MN 
Age 
adjusted 
 
Beta 
Estimate 
 
 
Std. 
Error 
 
p-value 
Arthritis 
Yes 
No 
 
15 
84 
 
12.3 + 1.3 
12.3 + 0.8 
 
-3.9 + 1.2 
0.2 + 0.7 
 
-0.4348 
 
0.1242 
 
0.0005* 
Migraines 
Yes 
No 
 
17 
82 
 
12.6 + 1.6 
12.2 + 0.8 
 
-0.4 + 0.7 
-0.3 + 1.2 
 
0.0537 
 
0.1167 
 
0.645 
High Blood Pressure 
Diagnosed 
Not Diagnosed 
 
27 
78 
 
17.9 + 1.8 
11.2 + 0.8 
 
1.7 + 1.8 
-0.7 + 0.7 
 
0.1103 
 
0.1414 
 
0.435 
Cancer 
History of cancer 
Never had cancer 
 
16 
89 
 
16.3 + 2.3 
12.2 + 0.8 
 
-0.3 + 2.4 
-0.1 + 0.7 
 
-0.0814 
 
0.1192 
 
0.495 
Heart Disease 
Diagnosed  
Not Diagnosed 
 
11 
94 
 
16.8 + 1.2 
12.4 + 0.9 
 
-0.7 +1.4 
0 + 0.8 
 
-0.1535 
 
0.074 
 
0.0381* 
Allergies 
Yes 
No 
 
44 
55 
 
14.1 + 1.3 
10.8 + 0.7 
 
0.8 + 1.2 
-1.4 + 0.6 
 
0.1306 
 
0.042 
 
0.0019* 
BMI 
Obese 
Overweight 
Normal weight 
Underweight 
 
19 
21 
43 
14 
 
14.8 + 1.9 
16.5 + 1.8 
10.6 + 0.8 
8.25 + 1.3 
 
0.8 + 1.2 
1.3 + 1.8 
-1.8 + 0.7 
-0.2 + 1.3 
 
0.1045 
 
0.0585 
 
0.0742 
*Statistically significant (p<0.05) 
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Table 4. Age-corrected univariate regression analysis of association of 
lifestyle factors with lymphocyte micronuclei frequencies.  
Lifestyle Predictor N MN 
Frequency/1000 
binucleates 
(mean ± s.e.) 
MN 
Age 
adjusted 
 
Beta 
Estimate 
 
 
Std. 
Error 
 
p-value 
Tobacco  
Past and current users 
Non-users 
 
23 
82 
 
16.0 + 2.1 
12.0 + 0.8 
 
1.5 + 1.9 
-0.5 + 0.7 
 
0.0004 
 
0.1002 
 
0.996 
Alcohol  
Alcoholic 
Everyday 
Few times per week 
One per week or less 
Never 
 
2 
6 
8 
23 
59 
 
15 + 0.5 
14 + 3.7 
11.7 + 1.5 
14.9 + 1.6 
10.9 + 0.9 
 
0.1 + 3.6 
0.4 + 4.6 
-1.8 + 2.0 
1.2 + 1.4 
-1.1 + 0.8 
 
-0.0032 
 
0.0443 
 
0.942a 
Fruit  
5 days per week or more 
less than 5 days per week 
 
64 
35 
 
11.3 + 0.7 
14.1 + 1.6 
 
-1.5 + 0.6 
1.5 + 1.4 
 
 
-0.211 
 
0.0877 
 
0.0162* 
Folate enriched bread  
5 days per week or more 
less than 5 days per week 
 
49 
50 
 
10.6 + 0.8 
13.9 + 1.2 
 
-1.9 + 0.7 
1.0 + 1.1 
 
-0.1377 
 
0.0743 
 
0.064 
Leafy Green Vegetables 
5 days per week or more 
less than 5 days per week 
 
37 
62 
 
10.6 + 0.8 
13.3 + 1.0 
 
-3.0 + 0.7 
1.1 + 0.9 
 
-0.2979 
 
0.088 
 
0.0007* 
Vitamin C supplement 
5 days per week or more 
less than 5 days per week 
 
12 
87 
 
16.1 + 2.5 
11.8 + 0.7 
 
0.2 + 2.4 
-0.5 + 0.7 
 
0.1283 
 
0.1135 
 
0.258 
Calcium Supplement 
5 days per week or more 
less than 5 days per week 
 
21 
78 
 
14.1 + 1.3 
11.8 + 0.8 
 
-1.0 + 1.1 
-0.3 + 0.8 
 
0.0389 
 
0.0985 
 
0.693a 
Vitamin E supplement 
5 days per week or more 
less than 5 days per week 
 
10 
89 
 
18.4 + 4.1 
11.6 + 0.6 
 
2.6 + 4.1 
-0.8 + 0.6 
 
0.264 
 
0.1179 
 
0.0251* 
Vitamin D supplement 
5 days per week or more 
less than 5 days per week 
 
14 
85 
 
15.5 + 2.2 
11.8 + 0.8 
 
0.3 + 2.0 
-0.5 + 0.7 
 
0.082 
 
0.1143 
 
0.473 
Fish Oil supplement 
5 days per week or more 
less than 5 days per week 
 
15 
84 
 
14.8 + 2.4 
11.8 + 0.7 
 
-0.1 + 2.3 
-0.5 + 0.6 
 
0.0928 
 
0.1067 
 
0.384 
Multivitamin 
5 days per week or more 
less than 5 days per week 
 
35 
64 
 
15.3 + 1.1 
10.6 + 0.9 
 
-0.1 + 1.1 
-0.6 + 0.8 
 
0.3149 
 
0.1114 
 
0.0047*a 
*Statistically significant (p<0.05) 
 a association varies with age, see covariate model Table 6 
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 To determine if the observed differences in micronuclei frequencies of people 
having allergies or arthritis might also be confounded by medications used for their 
treatment, lists of medication usage for these conditions were also tabulated. However, 
the sample sizes of individuals taking medication for these conditions (only 4 of the 44 
individuals having allergies and only 4 of the 15 individuals having arthritis) was too 
small to allow for an unbiased statistical assessment.  
The micronuclei frequencies associated with three of the variables tested (alcohol 
use, multivitamin supplements, and calcium supplements) varied with age.  As a result, a 
covariate model was used to test for potential associations for these variables.  These 
covariate assays showed both alcohol intake (moderate) and multivitamin use to be 
associated with decreased micronuclei frequencies (Table 6). However, no significant 
change in micronuclei frequencies was detected for calcium supplement usage 
(borderline value). 
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Table 5. Age-corrected univariate regression analysis of association of 
medications with lymphocyte micronuclei frequencies. 
Medication N MN 
Frequency/1000 
binucleates 
(mean ± s.e) 
MN 
Age 
Adjusted 
Beta 
estimate 
Std. 
Error 
p-value 
ACE inhibitor 
Yes 
No 
 
7 
92 
 
18.1 + 1.0 
11.6 + 0.8 
 
-0.59 +1.4 
-0.41 + 0.7 
 
-0.4467 
 
0.1802 
 
0.0132* 
 Blocker 
Yes 
No 
 
11 
88 
 
16.3 + 1.2 
12.1 + 0.7 
 
1.72 + 1.3 
-0.69 + 0.7 
 
0.2746 
 
0.1630 
 
0.0920 
Calcium Channel Blocker 
Yes 
No 
 
4 
95 
 
15.3 + 3.1 
12.1 + 0.7 
 
-0.05 + 1.3 
-0.43 + 0.7 
 
0.1672 
 
0.1772 
 
0.3453 
Angiotensin II Receptor 
Blocker 
Yes 
No 
 
 
5 
94 
 
 
21.3 + 3.0 
11.3 + 0.7 
 
 
-0.58 + 3.5 
-0.41 + 0.7 
 
 
-0.1142 
 
 
0.1794 
 
 
0.5243 
Diuretic 
Yes 
No 
 
10 
89 
 
17 + 1.5 
12.0 + 0.8 
 
-6.07 + 2.8 
-1.14 + 0.6 
 
0.4638 
 
0.1261 
 
0.0023* 
* statistically significant (p<0.05) 
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Table 6. Covariate regression analysis of association of health 
history/lifestyle factors with lymphocyte micronuclei frequencies and age.   
Health History 
or Lifestyle 
Predictor 
Beta Estimate Std. Error z-value p-value 
Calcium 
Supplement 
 
0.013 0.007 1.818 0.069 
Alcohol 
 
-0.008 0.002 -3.390 0.001* 
Multivitamin -0.012 0.006 -1.954 0.050* 
* Statistically significant 
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Discussion 
 
The frequencies of spontaneous micronuclei observed in the adults (mean age of 
55) of this twin population (which ranged from 0.25% to 4.5%) were comparable to the 
frequencies observed in singletons having a similar mean age (58) that were studied by 
other investigators (range of 0.2% to 4.2%) (Bonassi et al., 2001), suggesting that the 
twins who were evaluated in this investigation are representative of the general 
population. As noted by others, a strong positive correlation was present between 
micronuclei frequencies and age (Bolognesi et al., 1999; Bonassi et al., 2001).  
Interestingly, our observation of a peak in micronuclei frequencies in the members of our 
60-69 year-old age group (1.1% to 4.5%) is also a finding that has been seen by other 
investigators, who have shown that the frequency of micronuclei appears to peak between 
ages 50-69, remaining either unchanged or slightly lower in the individuals who live to 
be 80 or older (Wojda and Witt 2003; Bolognesi et al., 1997).  In contrast to our data, 
which showed no effect of sex on the micronuclei frequencies observed over all the 
individuals studied, several researchers have reported a difference in micronuclei 
frequencies between adult men and women, with women usually having higher 
micronuclei frequencies than men (Bonassi et al., 2001). The reason for this contrasting 
observation is not clear, but may reflect the fact that our data set included individuals 
from a broader range of ages than those typically studied.  For example, 9 of the 22 study 
groups included in the Human Micronucleus Project (HUMN) found a higher frequency 
of micronuclei in males, and two of those studies also included children (Bonassi et al., 
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2001).  Additionally, a study by Bonassi et al. (1995) saw a dramatic increase in female 
micronuclei frequencies, but this increase was limited to women in age groups over 44 
years. When one examines the mean micronuclei frequencies of the 20 to 40 year-olds 
and the 50 to 70 year-olds from our study, which are the age groups most frequently 
included by others, the micronuclei frequencies of the females tend to be higher than 
those of males.   
Little information is available about micronuclei frequency rates in children. 
However, in their meta- and pooled analyses of baseline levels of micronuclei 
frequencies, Neri, et al. (2005) found the average micronuclei frequency in children age 
0-18 years to be 0.52% + 0.51%.  The average micronuclei frequency in the children 
participating in our study was 0.70% + 0.07%.  However, our study included children 
ages 7 to 18 years, while approximately 30% of the children in their study were younger 
than 7 years. Given that an age effect on micronuclei has been shown, even in the first 
two decades of life, this variation in frequencies seems likely to reflect the variation in 
study subject ages between investigations (Neri et al., 2003).  Neri, et al. (2005) also 
found no gender effect on micronuclei frequencies in children, consistent with our 
observations.    
Since micronuclei frequencies are increasingly used as a biomarker, it is 
important to know what factors influence their spontaneous frequency.  By studying 
twins, we were able to provide the first estimate of the proportion of variation in 
micronuclei frequencies that was attributable to unique environmental, common 
environmental, and/or additive genetic effects.   Interestingly, the ACE model fitting 
analyses, which were completed on age-adjusted data to account for the strong 
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correlation present with advancing age, showed the best fit for reduced models, in which 
the variation was best explained by both common environmental and unique 
environmental factors (CE); or by additive genetic and unique environmental factors 
(AE).  Both of these models (AE or CE) provided a significantly better fit than models 
attributing the observed variation to only additive genetic effects or only unique or 
common environmental exposures.  Similarly, the MZ (0.5) and DZ (0.42) twin 
correlation coefficients provided values that clearly showed the presence of an 
environmental influence, but did not readily allow one to discriminate between the 
additional effects arising from additive genetic versus common environmental influences.  
Thus, the frequency with which an individual forms micronuclei appears to be a complex 
trait that is determined by a mixture of unique environmental influences, as well as either 
additive genetic or common environment exposures.  Our continued studies of a larger 
number of twins should allow us to better recognize the contribution of environmental 
and/or genetic influences to the formation of micronuclei in humans.  
Although unique environmental effects do not appear to solely influence 
micronuclei frequencies, they were consistently shown to contribute to the observed 
variation in frequencies.  Therefore, data from the health history questionnaires were 
analyzed to determine if specific environmental/health factors could be identified that 
were consistently associated with an increased or decreased frequency of micronuclei.  
Of the 7 health conditions that were assessed (Table 3), only three conditions (heart 
disease, arthritis, and allergies) were shown to be significantly associated with 
micronuclei frequencies after age adjustment.  Specifically, individuals with allergies had 
substantially larger micronuclei frequencies compared to individuals without allergies, 
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while individuals who reported arthritis or heart disease had significantly lower 
micronuclei frequencies compared to individuals without these conditions.  
The assessment of heart disease in this study cohort was compromised because it 
was self-reported and the study participants differed in their inclusion criteria.  Some 
individuals reported having heart disease because they had high cholesterol levels or high 
blood pressure, or both, while others only reported heart disease if they had experienced a 
heart attack. Because of this complication, the data were less subjectively analyzed by 
evaluating these individuals based on the medications that were prescribed for treatment 
by their physician.  The medications that were used by 4 or more individuals included 
ACE inhibitors, beta blockers, calcium channel blockers, angiotensin II receptor blockers, 
diuretics, statins, and aspirin.  Of the more commonly used medications, ACE inhibitors 
were found to be associated with significantly decreased micronuclei frequencies 
(p=0.013), while diuretics were associated with significantly increased micronuclei 
frequencies (p=0.0002) (Table 5).  These findings are in agreement with previous results 
that showed the use of diuretics in vitro (specifically hydrochlorothiazide) was associated 
with increased micronuclei frequencies (Andrianopoulos et al. 2006), while ACE 
inhibitors (specifically Captopril) significantly decreased micronuclei frequencies 
(Hosseinimehr et al., 2007).  However, in this latter study, micronuclei frequencies were 
assessed in bone marrow cells from mice following irradiation, with no other studies in 
humans being reported.  
Although the sample size of this study (n=115 individuals) was smaller than that 
used by some other investigators whose primary aim was to identify potential dietary and 
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lifestyle influences on micronuclei frequencies (reviewed in Battershill et al., 2008), 
significant differences were observed for both dietary patterns and alcohol usage. 
The regular inclusion (at least 5 days per week) of fruit and leafy green vegetables 
in the study participants’ diet was associated with a significant decrease in their 
micronuclei frequencies.  In addition, a trend toward a reduced frequency of micronuclei 
was observed for people reporting a consistent intake of folate-enriched bread.  
Collectively, these data suggest that folate may be important for regulating micronuclei 
frequencies, providing a “protective” effect that is associated with a decrease in 
frequency. This finding confirms the observations of other researchers, who have also 
reported folate usage to be associated with decreased micronuclei frequencies (Fenech 
2001; Fenech 2002; Fenech et al., 2005; Fenech and Rinaldi, 1994; Abramsson-
Zetterberg et al., 2006; Fenech 1998; Titenko-Holland et al., 1998).  Given that folate is 
required for DNA synthesis and repair, with it acting as a methyl donor for thymidylate 
synthesis, it is understandable that increased folate ingestion is associated with decreases 
in micronuclei frequencies (Fenech 2001). 
The influence of ingesting supplemental vitamins was also evaluated. Of the 
vitamins assessed (C, E, D, calcium, fish oil/omega 3 fatty acids, and multivitamins) only 
vitamin E and multivitamin ingestion were found to significantly influence micronuclei 
frequencies. The use of vitamin E supplements was associated with an increased 
frequency of micronuclei.  Other investigators who have studied this effect have reported 
varied results, with increases, decreases and no effect being seen for Vitamin E and C 
ingestions and micronuclei frequencies (Battershill 2008).  Interestingly, Fenech, et al. 
(2005), observed a decreased frequency of micronuclei with vitamin E intake, but did 
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note an increased frequency of micronuclei with biotin, riboflavin and pantothenic acid 
ingestion.  It is also interesting to note that vitamin E is found in many fruits and leafy 
green vegetables (along with folate, iron, calcium, and vitamins A, K, C), yet our sample 
showed a decreased frequency of micronuclei associated with their consumption. Thus, 
the protective influence conferred from the ingestion of these fruits/vegetables may arise 
primarily from the other components (such as folate), or the effect of vitamins may be 
varied depending on whether they are ingested as a supplement (perhaps over usage) 
versus ingested as a component of natural foods.  
In addition to looking at individual vitamins, multivitamin use was evaluated and 
found to be associated with a decreased frequency of micronuclei (with the effects co-
varying with age).  The individual components of the daily multivitamins were not 
reported, so we are unable to directly associate the positive effects to a key component(s).     
The effect of tobacco and alcohol usage on micronuclei frequencies of the adults 
who participated in this study was also evaluated.  Like several investigators (specifically 
the HUMN project which included over 5000 individuals), we found tobacco usage to 
have no significant influence on micronuclei frequencies (Bonassi et al., 2001).  
However, the study results of other investigators have shown an increased frequency of 
micronuclei with tobacco usage (Fenech 1993; Schneider et al., 2001), suggesting that the 
effect, if present, may vary with specific products consumed or be influenced by other 
factors (such as diet or other susceptibility factors).  
The association of alcohol use on the micronuclei frequencies of the adults in this 
study was shown to co-vary with age. In the covariate model factoring age effects, 
alcohol use was shown to be associated with decreased micronuclei frequencies. While 
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the generalized effect of alcohol on micronuclei frequencies has been noted to provide 
varied results (Battershill 2008), researchers have consistently found an increased 
frequency of micronuclei with alcohol use in individuals having genetic variants in the 
alcohol metabolizing enzyme, alcohol dehydrogenase (Ishikawa et al., 2006; Kim et al., 
2005).  Teo and Fenech (2008) suggest an interaction between folic acid and alcohol use, 
where increased folic acid protects against the DNA damage caused by increased ethanol 
use.  However, a factor confounding the interpretation of an association between alcohol 
consumption and micronuclei frequencies in this current study, as well as studies 
completed by other investigators, is the potential variation in the effect of moderate to 
low alcohol use (which may have no effect) compared to excessive alcohol usage, the 
latter of which has been associated with the presence of increased frequencies of 
micronuclei (Castelli et al., 1999; Maffei et al., 2002). 
In summary, the frequency of spontaneously arising micronuclei in humans 
appears to be a complex trait that is influenced by unique environmental factors as well 
as other factors (such as additive genetic or common environmental effects).  Recognition 
of the factors contributing to the baseline level of micronuclei is important for helping to 
better design studies that include the assessment of micronuclei frequency data for 
evaluating agents hypothesized to influence genomic instability. 
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Chapter 3. 
 
The numerical contents of sex chromosome containing micronuclei and the 
corresponding binucleates 
 
 
Introduction 
     
DNA damage and chromosomal instability are commonly associated with 
disease; most notably cancer. The cytockinesis-blocked micronculeus (CBMN) assay 
has become one of the most frequently used tools for assessing chromosomal 
abnormalities that have been acquired in the somatic cells of an individual, particularly 
in response to environmental exposures (Fenech 2006; Battershill et al., 2008).  The 
popularity of this assay stems, in part, from its ability to provide an accurate alternative 
to the time consuming process of identifying chromosomal damage through the analysis 
of individual metaphase spreads. Briefly, by scoring micronuclei (which are small 
chromatin-containing structures that were not incorporated into daughter nuclei 
following cell division), the CBMN assay provides information regarding the frequency 
of chromosomal aberrations present in somatic cells prior to the influences of selective 
growth pressures (Fenech and Morley, 1985). Thus, this technique is helpful in 
identifying genotoxic agents.  
Studies from the Human Micronucleus (HUMN) consortium have shown 
advancing age to be consistently associated with an increased frequency of spontaneously 
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occurring micronuclei in adults (Bonassi et al., 2001).  However, the underlying 
mechanisms leading to this age-related increase are not known.  One approach that 
investigators have used to gain insight about the underlying chromosomal errors that 
result in the formation of micronuclei has been to characterize their chromatin content to 
determine if consistent patterns emerge.  While one cannot directly visualize 
chromosomes in micronuclei, their chromatin content can be inferred using fluorescence 
in situ hybridization methodologies (Norppa and Falck, 2003). Through the use of 
pancentromeric and pantelomeric probes, investigators have inferred that the majority of 
spontaneously occurring micronuclei contain a single, intact chromosome (Leach and 
Jackson-Cook, 2001; Wojda and Witt, 2003; Lindberg et al., 2008).  Furthermore, in 
adults the sex chromosomes (chromosomes X and Y) are most frequently excluded into 
micronuclei, with this frequency increasing with age (Norppa and Falck, 2003).  While 
these studies have provided information for adults, very few of these investigations have 
included children, in part due to their low frequency of micronuclei. In one such study, in 
which the micronuclei present in the cells from 10 children (5 males and 5 females) were 
evaluated, Guttenbach et al. (1994) found 8% of micronuclei in females (ages 1-10 years) 
to contain X chromatin, with  Y chromatin being present in 14% of the micronuclei in 
males (ages 0.5-4 years).  Hando et al. (1994) and Nath et al. (1995) found no 
micronuclei containing sex chromosomes in the newborns they studied.  Thus, little is 
known about the age at which the apparently preferential exclusion of sex chromosomes 
into micronuclei is initiated in humans.   
Therefore, the primary aim of this study was to determine if there is a difference 
in the proportion of micronuclei that contain sex chromosomes in adults (19-81 years) 
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compared to children (7-15 years). This goal was achieved by scoring the number of 
centromeric signals present in micronuclei and their corresponding binucleates using 
probes specific for the pericentromeric regions of the X and Y chromosomes.    
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Materials and Methods 
 
Sample Ascertainment 
A total of 59 individuals (37 males and 22 females) were ascertained through the 
Mid-Atlantic Twin Registry, which is based at Virginia Commonwealth University. The 
individuals included in this study were selected from a larger, ongoing twin study, with 
their selection being: (1) random (n= 8); or (2) based on the individual having 5% or 
more of their micronuclei that contained chromatin from a sex chromosome [as 
ascertained from our studies using spectral karyotyping (n= 51) (see chapter 4)]. After 
providing informed consent (VCU IRB protocol 179), participants submitted blood 
samples.  The peripheral blood specimens were drawn by the study participant’s health 
care provider and shipped to our laboratory via an overnight delivery carrier.   
 
Cell Culture 
  The cultures to assess micronuclei frequencies were established with lymphocytes 
[using Histopaque-1077 (Sigma)] according to the protocol of Fenech (1993). Briefly, 
cytochalasin B (3.0 μg/ml; Sigma, 14930-92-2) was added to the cells 44 hours after 
culture initiation. At 72 hours, binucleate interphase cells were harvested using standard 
techniques, which included a 10-minute incubation in hypotonic solution (0.075 M KCl), 
and serial fixation (three times using a 3:1 methanol: acetic acid solution). Slides were 
made following standard procedures (Leach and Jackson-Cook, 2001).  
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FISH Procedure 
  For males, the sex chromosomal contents of the micronuclei were determined 
through the simultaneous hybridization of 3 differentially colored probes according to 
standard procedures (Abbot Molecular). The pericentromeric probes used included ones 
specific for the X chromosome (DXZ1; Spectrum Aqua); the Y chromosome (DYZ3; 
Spectrum Orange); and chromosome 17 (D17Z1; Spectrum Green), with the latter probe 
being used as an autosomal control.  For females, the same X (DXZ1) and autosomal 
(D17Z1) probes were used, but the Y chromosomal probe was not evaluated since 
previous GTG-banding studies confirmed that none of these females had a Y 
chromosome. The target (interphase chromatin) and probe DNA were denatured 
separately. The chromatin on the slides was denatured using a 70% formamide solution 
(pH 7.0) at 73C for 3 minutes. Following denaturation, the slides were briefly rinsed in 
cold water and then dehydrated using an ethanol series (70%, 85%, and 100% for 2 
minutes each).  The probes (which were prepared using a 1:100 dilution in a C-Denhyb 
solution, Insitus Biotechnologies, Albuqueque, New Mexico) were denatured at 94C for 
10 minutes, and then cooled on ice for 2 minutes.  Following the addition of the 
denatured probe to the denatured slide, the slides were placed in a humidified chamber 
and hybridized at 37C overnight. Non-specific binding of probes was removed by 
washing in a 0.4xSSC/0.3%NP-40 solution at 73 for 2 minutes, followed by a one 
minute wash at room temperature in a 2xSSC/0.1%NP-40.  To visualize the binucleates 
and micronuclei, the slides were counterstained with DAPI II (Abbott). 
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FISH scoring 
  Slides were scored on an Axioskop equipped with triple- and single-band pass 
filters (Zeiss). Only binucleates that contained one or more micronuclei, as visualized 
with DAPI staining, were scored.  Following their identification, the number of 
fluorescent signals for each probe in the binucleates and micronuclei were scored (Figure 
5).  Representative images of the cells having micronuclei were captured using an image 
analysis system (Applied Spectral Imaging, Carlsbad, CA).  
 
Statistics 
The number of signals present in the micronuclei were evaluated for consistent 
patterns. Given that the frequencies of the micronuclei were not normally distributed, a 
square root transformation of the data was performed.  Following transformation, the 
proportion of patterns present in the children and adults was determined using a general 
linear modeling (GLM) analysis [ =0.05; R (Version 2.9.1) software analysis system]. 
Gender and age were factors that were evaluated in the model.  
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Figure 5.  Representative images of binucleates and their micronucleus 
following FISH.  The cells shown are from two males.  (a) The micronucleus in 
this image contains chromatin from the Y chromosome (orange signal). The 
upper binucleate contains one aqua signal (X chromatin) and two green signals 
(17 chromatin), while the lower binucleate has one orange signal (Y chromatin), 
two green signals (17 chromatin), and one aqua signal (X chromatin). This 
binucleate was scored as having a hypodiploid cell pattern.  (b) This 
micronucleus contains two orange signals (Y chromatin). The corresponding 
binucleate was scored as euploid because both cells have a normal complement 
for the chromosomes evaluated (1 aqua, 2 green, and 1 orange signal). 
(a). (b) 
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Results 
Cellular distribution of sex and autosomal probe signals 
Following hybridization, a total of 2,749 micronuclei were scored from the 37 
male study participants, with 13.2% of the micronuclei containing Y chromatin, 5.7% 
containing X chromatin, and only 1.5% having chromatin from chromosome 17.  For all 
three chromosomes scored (X, Y, and 17), the majority of micronuclei appeared to 
contain a single centromeric region (51.9%, 58.8%, and 92.9%, respectively). Similarly, 
of the 1,868 micronuclei scored from the 22 female study participants, 15.8% contained 
chromatin from the X chromosome, with only 2.1% having chromatin from chromosome 
17.   As in the males, the majority of micronuclei in the females appeared to contain a 
single centromeric region of the chromosome scored (54.4% for the X chromosome, and 
92.1% for chromosome 17).  
The probe signal patterns present in the total of 1,017 binucleated cells having at 
least one micronucleus with a signal for chromosomes X, Y, or 17 revealed the presence 
of three primary types of cells as shown in Figures 6, 7, 8, and 9. These consistently 
observed cell types included those having binucleates with: (1) a hyperdiploid 
complement [having one or more additional signals when compared to euploid 
expectations (X,Y,17,17 or X,X,17,17) in at least one binucleate], with the chromosomal 
region involved in the imbalance also being present in the micronucleus; (2) a 
hypodiploid complement in at least one binucleate (missing a signal for one of the 
chromosomal regions evaluated), with the missing signal being excluded into the 
micronucleus; or (3) a euploid binucleate complement, with an apparent chromosomal 
imbalance being “corrected” through its exclusion into the micronucleus. 
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Overall, the hypodiploid binucleate cell type was seen most frequently (63.2% of 
total), followed by the euploid binucleate pattern (28.7%) and the hyperdiploid cell type 
(8.1%). This pattern was found for each chromosome analyzed (Figure 6).      
 
Binucleate FISH and age 
To determine if the proportion of binucleate/micronuclei patterns varied with age 
or gender, a general linear model (GLM) analysis was completed.  In the males, the 
percent of cells having the “corrected” euploid binucleate micronuclear pattern for the Y 
chromosome significantly decreased with age (p=0.026), while those having a 
hypodiploid binucleate pattern tended to increase with age (Figure 7).  Similarly, in the 
females, the proportion of cells having a “corrected” euploid binucleate micronuclear 
pattern for the X chromosome was significantly decreased with age (p=0.030), while the 
proportion of cells having a hypodiploid binuclear complement tended to increase with 
advancing age (Figure 8).  In contrast, for the males, no significant divergence in the 
proportion of binucleates having an unbalanced (hyperdiploid or hypodiploid) or 
balanced complement for the X chromosome was observed with age (p=0.45) (Figure 9).  
Moreover, no significant difference in the proportion of hyperdiploid binucleates was 
observed for the X (males or females) or Y chromosome (males) (Figures 7, 8, and 9). 
The number of micronuclei containing chromatin from chromosome 17 (total of 81) was 
too small to allow for a meaningful statistical analysis of age-related patterns for this 
autosome. 
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Hypodiploid 
Hyperdiploid 
Euploid 
“Corrective” 
Figure 6. Primary patterns observed in binucleates and micronuclei. (a) The three 
generalized types of combinations of binucleates observed are shown as they appear 
for the Y chromosome (for the X chromosome see figures 8 and 9) (b) The proportion 
of total cells (all study subjects) having each of the three cellular patterns 
[hyperdiploid (gray); hypodiploid (white); and euploid (black)] in males and females 
are shown for each chromosome (n=number of binucleates scored for each 
chromosome/gender).  
(b) (a) X chromosome 
Y chromosome 
Chromosome 17 
Females 
n=190 n=269 
Males 
n=41 n=38 
n=479 
Hyperdiploid
Hypodiploid
Euploid
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Figure 7. Percent of each binucleate type for the Y chromosome by age. 
The bar graph represents the percentage of binucleates that were 
hyperdiploid (gray), hypodiploid (white), and euploid (black). The age 
groups evaluated are shown on the X axis, with the percentage of binucleates 
being shown on the Y axis.  
0
10
20
30
40
50
60
70
80
7yrs-
9yrs
10yrs-
19yrs
20yrs-
29yrs
30yrs-
39yrs
40yrs-
49yrs
50yrs-
59yrs
60yrs-
69yrs
70yrs-
79yrs
80yrs
over
Y Chromosome 
P
er
ce
nt
 o
f b
in
uc
le
at
es
 
Euploid 
Binucleate 
(corrected  
by MN) 
Hypodiploid 
Binucleate 
Hyperdiploid 
Binucleate 
  48
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Females
0
10
20
30
40
50
60
70
10yrs-
19yrs
20yrs-
29yrs
30yrs-
39yrs
40yrs-
49yrs
50yrs-
59yrs
60yrs-
69yrs
70yrs-
79yrs
80yrs
over
P
er
ce
nt
 o
f b
in
uc
le
at
es
 X Chromosome 
Hyperdiploid 
Binucleate 
Hypodiploid 
Binucleate 
Euploid 
Binucleate 
(corrected  
by MN) 
Figure 8. Percent of each binucleate type for the X chromosome by age in 
females. The bar graph represents the percentage of binucleates that were 
hyperdiploid (gray), hypodiploid (white), and euploid (black). The age groups 
evaluated are shown on the X axis, with the percentage of binucleates being shown on 
the Y axis.  
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Figure  9. Percent of each binucleate type for the X chromosome by age 
in males The bar graph represents the percentage of binucleates that were 
hyperdiploid (gray), hypodiploid (white), and euploid (black).  The age 
groups evaluated are shown on the X axis, with the percentage of binucleates 
being shown on the Y axis.  
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Discussion 
       
In order to better understand the underlying basis for the observation of an age-
related increase in sex-chromatin containing micronuclei, we evaluated micronuclei and 
their corresponding binucleates from males and females of varying ages.  We expanded 
upon previously reported data by analyzing the number of signals that were present for 
the pericentromeric region of the sex chromosomes (as well as an autosome) in the 
binucleates, in addition to their corresponding micronuclei. The most frequently observed 
pattern that was detected in the study participants resulted in a hypodiploid sex 
chromosomal complement in a binucleate(s), as a result of the exclusion of that 
chromosome into a micronucleus.  This finding is in agreement with the results of  
Hando, et al. (1994), who included a description of the binucleate signal patterns in their 
study of micronuclei containing X chromatin.  In the adult females they studied, who 
ranged in age from 20 to 79 years, the only patterns reported were those resulting in a 
hypodiploid binucleates. While these investigators also obtained blood samples from 8 
newborns, those samples were excluded from their X chromatin FISH studies due to the 
low frequency of micronuclei present. In contrast to their results, we also observed 
patterns resulting in hyperdiploid complements, as well as euploid complements in the 
binucleates.  
Of particular interest was this latter category, in which the exclusion of a sex 
chromosome into a micronucleus resulted in the establishment of a balanced complement 
for the binucleate (possible trisomy rescue). The proportion of these “corrective” cells 
was significantly increased in the younger compared to older females and males for the X 
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and Y chromosomes, respectively. This age-related divergence in cell type pattern also 
included a trend toward an increase in the proportion of binucleates having loss for a sex 
chromosome (Y in males; X in females) in the older study subjects.  
One can theorize that the “corrective” cells observed in this study might have 
arisen from a mitotic error, possibly caused by DNA damage and/or aneugenic 
environmental exposure, and that the formation of the micronucleus resulted from the 
ability of the cell cycle checkpoints (or alternative mechanisms) to correct this error. 
These processes may be less effective for detecting abnormalities resulting in 
chromosomal loss versus gain and/or may decrease in efficiency with age. Thus, the age-
related changes that arise from loss mechanisms lead to an overall age-related increase in 
the frequency of micronuclei. Given the paucity of micronuclei containing chromosome 
17 in this study, we were unable to determine if this phenomenon is true for autosomes, 
as well as sex chromosomes.  
  In summary, the pattern of sex chromosomal imbalance in binucleates containing 
a micronucleus varies with age.  In addition to reflecting the presence of cell loss, which 
appears to be an age-related change, the presence of micronuclei may reflect a “trisomy 
rescue” event.  While this information supports the conclusion that micronuclei 
frequencies serve as an indication of DNA damage and/or imbalance, in some cases, 
particularly when seen in children, their presence may also represent the cell’s ability to 
correct for acquired damage.   Therefore, when analyzing micronuclei frequencies, it may 
be informative to examine the contents of the binucleates, in addition to the micronuclei, 
to facilitate the recognition of varying cellular responses to environmental or genotoxic 
exposures.  
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Chapter 4. 
 
 
Chromosomal contents of micronuclei determined using SKY 
 
 
Introduction 
 
Micronuclei frequencies are known to increase with age and have been 
associated with increased DNA damage.  The cytokinesis-blocked micronucleus 
(CBMN) assay has become a useful tool for assessing micronuclei frequencies.  While 
there is increasing information on the frequencies of micronuclei, there is minimal data 
regarding the chromosomal contents of the micronuclei.  While one cannot directly 
visualize chromosomes in micronuclei, their chromatin content can be inferred using 
fluorescence in situ hybridization methodologies (Norppa and Falck, 2003). Through 
the use of pancentromeric and pantelomeric probes, investigators have determined that 
the majority of spontaneously occurring micronuclei contain a single, intact 
chromosome (Leach and Jackson-Cook, 2001; Wojda and Witt, 2003; Lindberg et al., 
2008).  In an attempt to determine the chromosomal contents of micronuclei, several 
investigators have used probes that are specific for the sex chromosomes (either 
centromeric probes or painting probes), with small subset of autosomes being evaluated, 
including chromosomes 1, 2, 9, 11, 16, 21, and 22 (reviewed by Norppa and Falck, 
2003).  Of the chromosomes evaluated, the sex chromosomes have been the most 
frequently observed chromosome present in the micronuclei, with their frequencies 
increasing with age (reviewed by Norppa and Falck, 2003).  However, the vast majority 
of the existing data has been collected from assessments of micronuclei present in 
adults, and the few studies that have investigated the chromosomal contents of 
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micronuclei in children have limited sample sizes, with the number of children studied 
ranging from 8 to 18 (Guttenbach et al., 1994; Hando et al., 1994; Nath et al., 1995).    
  Technological problems that have been encountered by investigators striving to 
determine the chromosomal contents of micronuclei have included: (1) incomplete 
characterization of the chromatin present in the micronuclei since enumeration probes 
generally hybridize only to chromatin including the centromere region (thus providing 
no information for micronuclei containing acentric fragments); and (2) the number of 
chromosomes that can be evaluated using a whole chromosome painting approach  (or a 
centromeric probe approach) is limited due to a small number of differentially labeled 
probes.  Thus, the data pertaining to autosomal inclusion in micronuclei, which has been 
gained through these techniques, is inconclusive.  Two groups (Tucker et al., 1996; 
Fauth et al., 1998 and 2000) reported that chromosome 9 was frequently excluded into 
micronuclei. However, Tucker, et al. (1996) based this conclusion on only the 
observation of two chromosome 9 positive micronuclei (from a total of 96 evaluated), 
and Fauth, et al. (1998, 2000) completed their study using only three individuals.  Yet 
another investigative team reported that chromosome 2 was present in micronuclei with 
an increased frequency, but this conclusion was based on studies completed from a 
single individual (Peace et al., 1999).      
To circumvent the methodological problems of determining the chromosomal 
contents of micronuclei arising from conventional FISH methodologies, Leach and 
Jackson-Cook (2001) developed a novel assay exploiting spectral karyotyping (SKY) 
technology for the detection of chromosome contents in micronuclei.  This approach 
offered a huge advantage over the two previously used techniques since SKY allowed 
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for the simultaneous detection of all 24 chromosomes.  However, like other 
investigations, this initial study was based on the assessment of only three females.  
Therefore, the primary aim of our study was to expand upon previous work and 
determine the baseline frequency with which sex chromosomes, as well as autosomes, 
are excluded into micronuclei by analyzing the chromosomal contents of micronuclei in 
males and females through the use of spectral karyotyping, while simultaneously 
determining if the pattern of chromosome involvement varied with age.      
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Materials and Methods 
 
Sample Ascertainment 
  A total of 79 individuals (42 males and 37 females) were ascertained through the 
Mid-Atlantic Twin Registry, which is based at Virginia Commonwealth University. The 
frequency of micronuclei was determined for each of the 115 study participants according 
to the protocol of Fenech (2003).  Spectral karyotyping was performed on those 
individuals having 0.4% or higher frequency of micronuclei.  After providing informed 
consent (VCU IRB protocol 179), participants submitted blood samples.  The peripheral 
blood specimens were drawn by the study participant’s health care provider and shipped 
to our laboratory via an overnight delivery carrier.   
 
Cell Culture 
Lymphocytes were isolated using Histopaque-1077 (Sigma) and lymphocyte 
cultures were established according to standard procedures (Moorhead et al. 1960).  
Cytochalasin B (Sigma, 14930-92-2) was added to the cultures 44 hours after initiation at 
a concentration of 3.0 μg/ml. Cultures were harvested at 72 hours.  Cells were treated 
with hypotonic solution (10 minutes with 0.075 M KCl), and fixed three times (3:1 
methanol: acetic acid). Slides were made following standard procedures (Leach and 
Jackson-Cook, 2001), and aged at room temperature for four days before beginning the 
SKY procedure. 
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Spectral Karyotyping 
SKY was performed according to the manufacturer’s (Applied Spectral Imaging) 
protocol.  Briefly, the chromatin on the slides was denatured using a 70% 
formamide/2xSSC solution (pH 7.0) at 73C for 2 minutes. Following denaturation, the 
slides were briefly rinsed in cold water and then dehydrated using an ethanol series (70%, 
85%, and 100% for 2 minutes each).  The SKY probe (Applied Spectral Imaging) was 
denatured at 75C for 10 minutes, followed by suppression hybridization at 37C for 60 
minutes. Following the addition of the denatured probe to the denatured chromatin, the 
slides were placed in a humidified chamber and hybridized at 37C for approximately 44 
hours.  Non-specific binding of the probe was removed by washing in a 
0.4xSSC/0.3%NP-40 solution at 73C for 2 minutes, followed by a one minute wash at 
room temperature in a 2xSSC/0.1%NP-40. Indirectly labeled probes (biotin and 
digoxigenin) were detected using buffers with avidin-Cy5, mouse anti-digoxin and goat 
anti-mouse conjugated to Cy5.5 (provided by manufacturer). All incubations were for 40 
minutes at 37C.  To visualize the binucleates and micronuclei, the slides were 
counterstained with DAPI/Antifade (Applied Spectral Imaging) and viewed using a Zeiss 
Axioskop equipped with a DAPI filter and a custom triple-band pass filter (Chroma).  For 
analysis, the micronuclei were captured using a SpectraCube system (Applied Spectral 
Imaging) and analyzed using the SKY software.  At least one metaphase spread was 
analyzed per slide to ensure proper hybridization of the SKY probe cocktail.  Once 
proper hybridization was confirmed, each micronucleus, along with the surrounding 
nuclei, was captured and analyzed. An example of the captured images is found in Figure 
10.        
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a. b. c. 
Figure 10. Representative binucleate and micronucleus following SKY. 
These structures are shown as they appear with reverse DAPI staining (a); 
the spectral image (b.) and the classified image (c.) The chromatin present in 
this micronucleus was determined to have originated from chromosome 11. 
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SKY assignment confirmation using FISH (WCP and CEP) 
After analysis, slides were randomly chosen to assess the accuracy of the SKY 
classification.  These slides were washed in 70% formamide/2xSSC solution (pH 7.0) at 
70C for 2 minutes to remove the SKY probe. Slides were then stained with DAPI and 
viewed to ensure complete removal of the probe. After a brief wash in 2xSSC, the slides 
were hybridized with either a whole chromosome painting probe (WCP) or centromere 
enumeration probe (CEP).  The probes and slides were then co-denatured (75C for 2 min 
for WCP or 73C for 2 minutes for CEP).  Following co-denaturation, the slides were 
placed in a humidified chamber and hybridized at 37C overnight.  Non-specific binding 
of the probe was removed by washing in a 0.4xSSC/0.3%NP-40 solution at 73C for 2 
minutes, followed by a one minute wash at room temperature in a 2xSSC/0.1%NP-40.  
Slides were counterstained with DAPI II (Abbott Molecular) and viewed using a Zeiss 
Axioskop equipped with triple-band pass and single band pass filter sets (Abbott 
Molecular).   
  
Statistical Analysis 
Comparisons of the frequencies of chromosomal exclusion into micronuclei were 
performed using a contingency Chi-square test.  In order to limit type I errors, an alpha 
level of p<0.05 was used for all statistical tests. 
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Results 
 
Chromosomal contents in Micronuclei 
  Of the 3,611 micronuclei scored, the majority (89.6%) contained chromatin from 
a single chromosome.  Micronuclei were most frequently found to contain chromatin 
from the sex chromosomes, with 27.3% of micronuclei in females containing X 
chromatin and 27.6% of micronuclei in males containing Y chromatin (p<0.0001).  A  
non-random pattern of autosomal exclusion into micronuclei was also observed 
(p<0.0001), with chromosomes 4, 8, and 9 being present most frequently, and 
chromosomes 17 and 22 being present least frequently.  No significant difference in these 
patterns of autosomes were observed between the males and females studied (p=0.7) 
(Figure 11).  
 
Micronuclei contents with age 
A significantly lower frequency in the proportion of micronuclei containing sex 
chromosomes was observed in the children (7-19 years) compared to adults (25-81 
years), for both males (p<0.0001) and females (p<0.0001). However, no significant 
difference in autosomal patterns was observed with age (p=0.9) (Figures 12 and 13).  
 
SKY accuracy 
To determine the accuracy of the SKY methodology for evaluating the 
chromosomal contents of micronuclei, a total of 389 micronuclei were re-assessed using  
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Figure 11.  Distribution of chromosomes excluded into micronuclei in 
males (black) and females (white). The percentage of micronuclei (Y 
axis) that contained chromatin from each of the chromosomes (X axis) is 
shown.  
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Figure 12. Distribution of sex chromosomes in micronuclei with age. The 
percentage (Y axis) of X and Y chromosomes present in micronuclei seen in 
children (black) and adults (gray) are shown. The distribution observed in 
males is shown for the X (left histograms) and Y (center histogram) 
chromosomes. The distribution observed for the X chromosome in females is 
also shown (right histogram).    
  62
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0%
2%
4%
6%
8%
10%
12%
14%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Chromosome
Children n=447
Adults n=1604
P
er
ce
nt
 a
ut
os
om
e 
M
N
 
Figure 13. Distribution of autosomes excluded into micronuclei 
in children (black) and adults (white). The percentage of 
micronuclei (Y axis) that contained chromatin from each of the 
chromosomes (X axis) is shown.  
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single, chromosome-specific probes.  Agreement in the chromosomal classification was 
present for 83% of the micronuclei scored using centromeric probes, with agreements 
being observed for 89% of the micronuclei evaluated using whole chromosome painting 
probes.  An example of the image captured during these confirmation studies is found in 
Figure 14.  All cases having a discrepancy failed to show a hybridization signal for the 
chromosome evaluated in the micronucleus but did demonstrate sufficient hybridization 
of the probes in the binucleate.    
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SKY classification Painting Probes 
Figure 14.  Representative images showing confirmation of SKY 
micronuclei assessment using a painting probe.  The image on the left 
depicts a micronucleus classified by the SKY software as containing 
chromatin from chromosome 4. The image on the right depicts the same 
micronucleus after the SKY probe was stripped and the slide was re-
hybridized with the chromosome painting probes 4 (orange) and 12 
(green). The micronucleus hybridized orange, confirming the SKY 
classification. 
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Discussion 
 
SKY analysis was performed to determine if there was a non-random pattern of 
chromosomes excluded into spontaneously occurring micronuclei in healthy individuals. 
This technique allows for the examination of all 24 chromosomes in a single 
hybridization. The majority of micronuclei were found to contain chromatin from a single 
chromosome. In both males and females, the sex chromosomes were most frequently 
excluded into micronuclei. Chromosomes 4, 8, and 9 were also found with a significantly 
higher frequency than expected by chance, while chromosomes 17 and 22 were found 
much less frequently than expected.  This preferential exclusion of chromosome 9, which 
has been reported previously (reviewed by Norppa and Falck, 2003), is thought to be 
related to the large block of heterochromatin on this chromosome; however chromosomes 
1 and 16 also contain large blocks of heterochromatin, and these chromosomes were not 
found to have an increased frequency.  We found no difference in the pattern of 
autosomes present in the micronuclei studied from males compared to females. This 
observation is consistent with the results of studies reported by Wojda et al. (2007), who 
also did not find a gender difference in frequency of micronuclei containing the subset of 
autosomes they assessed using FISH techniques.   
  To determine if age influenced the distribution of specific chromosomes that were 
excluded into micronuclei, comparisons were made between adults (ages 25-81 years) 
and children (ages 7-19 years). Indeed, a significantly higher proportion of micronuclei 
containin sex chromosomes was seen in adults compared to children. This age-related 
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difference in sex chromosomal exclusion into micronuclei was observed in both the 
males and females. However, no significant differences in the proportion of micronuclei 
containing autosomes were detected with age or gender.  Wojda et al. (2007) found a 
similar effect in adults, noting that the frequency of sex chromosome micronuclei 
increased with age, but the frequencies of the five autosomes that they tested 
(chromosomes 1,4, 6, 8, and 20) did not vary with age.  
Given that the SKY methodology was developed for use on metaphase 
chromosomes, with software classification standards being established for a metaphase 
format, we performed confirmation studies, using chromosome-specific probes, for a 
subset of micronuclei. These studies allowed for an evaluation of the accuracy of this 
SKY methodology when used in this interphase cell format. These FISH confirmation 
studies, which primarily assessed sex chromosomal assignments, showed agreement 
between the FISH and SKY assays for 83% of micronuclei using centromeric 
enumeration probes (CEP), and 89% of the micronuclei using whole chromosome 
painting probes (WCP).  The variation in this number most likely reflects the difference 
in the two methods used. The accuracy determined by using the CEP probes was most 
likely lower because this probe only allows for confirmation of micronuclei containing 
the centromeric region and would not allow for confirmation of micronuclei having 
fragments of that chromosome that did not contain the centromere. Therefore, these 
studies could produce false negative results (with the SKY software correctly identifying 
the chromatin, which originated from a portion of the chromosome without the 
centromeric region [thus the CEP probe would not bind]). The agreement in assignment 
for 89% of the micronuclei, as confirmed through the use of WCP probes, is expected to 
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yield a better estimate the true accuracy of the SKY method, since the whole 
chromosome probes will bind to any region of the chromatin.   Collectively, these 
findings suggest that a fraction of the micronuclei may contain chromosomal fragments.   
In conclusion, there is a non-random pattern of chromosome exclusion into 
micronuclei, with the sex chromosomes being most frequently involved. The frequency 
of autosomes excluded into micronuclei does not appear to vary with age or gender.  This 
study further demonstrates the usefulness of the SKY method for the detection of 
micronuclei chromosomal contents.  The frequencies of autosome involvement in 
micronuclei detected in this study can serve as normal, baseline data for other 
researchers.        
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Chapter 5. 
 
Variation in global methylation profiles between identical twin pairs 
 
Introduction 
 
While acquired chromosomal changes in DNA (aneuploidy) were first noted 
nearly 50 years ago, it was only recently recognized that chromatin has the potential to 
undergo epigenetic changes with advancing age (Sedivy et al., 2008).  Epigenetic 
modifications, such as DNA methylation, play an important role in the control of gene 
expression and chromosome structure (Frigola et al. 2002; Peaston and Whitelaw, 2006).  
Simplistically, methylation typically prevents gene expression, while loss of methylation 
allows transcription.  However, the degree to which one’s methylation profile changes 
with age is unresolved, with some researchers reporting that methylation increases with 
age while others report an overall decrease in methylation with age (Golbus et al., 1990; 
Cooney, 1993; Vertino et al., 1994; Toyota et al., 1999; Geigl et al., 2004; Clayton et al., 
2005; Wojdacz and Hansen, 2006; Bollati et al., 2009). Furthermore, the cause(s) of these 
changes in methylation patterns with age, when present, are unknown.  Some believe it is 
a function of diet and environment, while others believe it to be a random process 
(Cooney, 1993; Fenech 2002; Jaenisch et al., 2003; Bjornsson et al., 2004; Peaston and 
Whitelaw, 2006).  It has been hypothesized that as humans age, they accumulate 
epigenetic and/or chromosomal changes over time (Wong et al, 2005; Petronis, 2006). 
Once multiple changes are acquired, these alterations may result in the development of an 
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age-related complex disease.  In fact, many cancer cells have been shown to develop 
epigenetic changes, with some cancer types showing alterations that lead to 
hypomethylation of genes, while others have shown hypermethylation changes (reviewed 
by Iacobuzio-Donahue, 2009). The possible randomness and unpredictable nature of 
these modifications in DNA methylation has been proposed to explain the observation of 
monozygotic (MZ) twins who are discordant for certain diseases (schizophrenia at 50% 
discordance for MZ twins, 70% for rheumatoid arthritis, and 80% for breast cancer), 
despite their having no evident differences in environmental exposure (King et al., 1992; 
Petronis, 2001; Singh et al., 2002).  The observation that there was no difference in the 
frequency of phenotypic discordance between MZ twins raised apart when compared to 
MZ twins raised together, led Wong et al. (2005) to suggest that the observed phenotypic 
divergence reflected a mechanism other than environment, implicating epigenetic 
alterations as a possible etiological factor.  This hypothesis has gained supported from 
several investigators, including Petronis (2001), who suggested that a large number of 
epigenetic changes could accumulate during the numerous mitotic divisions that are 
completed in somatic cells as an individual ages and that these changes could lead to 
diversity between two genetically identical individuals.  Indeed, in their paradigm 
shifting study, Fraga et al. (2005) found that patterns of epigenetic modifications in MZ 
twin pairs do diverge as they become older.  Martin (2005) described this phenomenon as 
epigenetic drift.  These alterations in an individual’s epigenetic profile appear to be much 
more prevalent than DNA mutations (Bennett-Baker, 2003).   
Since epigenetic mechanisms play a key role in establishing and maintaining 
chromosomal structure, specifically heterochromatin and euchromatin, it is possible that 
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epigenetic changes could be an underlying mechanism contributing to the acquisition of 
structural and numerical chromosomal abnormalities associated with aging.  For example, 
methylation abnormalities have been linked to whole chromosome gains and losses in 
colon cancer cells, linking aneuploidy to changes in methylation (Lengauer et al., 1997; 
Reviewed by Richardson 2002). And more recently, hypomethylation of transposable 
elements (LINE and Alu sequences) has been associated with increased genome 
instability in non-small cell lung cancer (Daskalos et al., 2009).   
Evidence that perturbations in methylation can result in increased frequencies of 
chromosomal abnormalities in humans has also been obtained through studies of people 
having immunodeficiency, centromeric region instability, facial anomalies (ICF) 
syndrome, which is a rare autosomal recessive condition resulting from a mutation in the 
methyltransferase gene (Kondo, et al. 2000). Individuals having ICF syndrome have an 
increased frequency of structural chromosomal abnormalities, with aneuploidy also being 
observed, albeit less frequently. Interestingly, the chromosomes of these patients show 
accelerated telomere shortening and telomeric dysfunction. However, the most striking 
observation regarding the preponderance of chromosomal abnormalities present in these 
individuals is that they have a non-random chromosomal distribution, with anomalies 
being seen most frequently for chromosomes 1 and 16, followed by chromosome 9, 
which are all chromosomes having large heterochromatic regions (Gisselsson et al., 2005; 
Ehrlich, et al., 2008).   
To  test the hypothesis that methylation alterations influence chromosomal  
aneuploidy in humans, Guttenbach and Schmid (1994) and Fauth et al. (1998)  treated 
cells with the drug 5-azacytidine, which induces hypomethylation. Both groups observed 
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an increased frequency of micronuclei containing the chromosomes 1, 9, and 16, which 
led them to conclude that undermethylation of heterochromatin may be associated with 
the loss of specific chromosomes.  In our own studies of spontaneously acquired 
chromosomal abnormalities in humans, we observed an increased frequency of losses for 
chromosomes 1, 9, and 16 in lymphocytes and buccal mucosa cells (Rehder, et al., 2009). 
One can speculate that the methylation status of these heterochromatic chromosomes may 
play a role in their increased propensity for age-related losses.  While there does seem to 
be a consistent trend toward methylation differences playing a contributory role to the 
acquisition of chromosomal abnormalities, it is unclear if these alleged differences arise 
in response to environmental exposures. 
One of the most straightforward means for detecting the presence of changes in 
methylation in humans is through the study of identical twins, who have identical 
genomic DNA.  Assuming that monozygotic twins are born with the same methylation 
profile, any variations in the methylation profile observed in adult identical co-twins are 
thought to reflect acquired changes.  
Thus, the primary aim of this small pilot study was to determine if acquired 
methylation differences could be detected between monozygotic twins having low 
compared to high micronuclei frequencies, as well as divergent environmental exposure 
histories. We hypothesize that the co-twins having increased variation in their 
micronuclei frequencies will also show more divergence in their methylation profiles.    
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Materials and Methods 
 
Sample 
     Two female monozygotic twin pairs were chosen from a larger ongoing study on the 
basis of their frequency of micronuclei, as well as their environmental/lifestyle histories. 
One pair (age 85) was very similar in environmental exposures, health history, and 
micronuclei frequencies, while the other pair (69 years old) was very different for these 
variables (Table 7). After providing their informed consent (VCU IRB protocol #179), 
the participants submitted blood samples and a completed health history questionnaire.  
Blood samples were collected by the participants’ health care providers. Following their 
collection, the samples were shipped to our laboratory via an overnight delivery carrier.   
 
DNA Isolation and Zygosity Determination 
Genomic DNA was isolated from whole blood using the Puregene DNA Isolation 
Kit (Qiagen).  The zygosity status of the twins was confirmed using 13 highly 
polymorphic short tandem repeat sequences (AmpFlSTR Profiler Plus and Cofiler kits 
from Applied Biosystems, Foster City, CA) according to standard procedures.  
 
MeDIP 
A methylated DNA immunoprecipitation assay (MeDIP) was performed 
according to the protocol of Mohn, et al. (2009) as shown in Figure 15. Briefly, genomic 
DNA was isolated from whole blood using the Puregene DNA Isolation Kit (Qiagen).  A 
20µg aliquot of DNA was sonicated at 30% power for 10 seconds for a total of 4 cycles  
  73
 
Table 7. Participant information for the methylation study. 
Individual Age Pair Micronuclei 
observed/1000 
binucleates 
High 
blood 
pressure
Heart 
disease
Alcohol 
usage 
Tobacco 
usage 
1 85 1 13 Yes Yes No No 
2 85 1 12 Yes Yes No No 
3 69 2 14 Yes No No No 
4 69 2 35 Yes No No Yes 
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Figure 15. Illustration of Methylated DNA Immunoprecipitation (MeDIP) 
procedure.  Whole genomic DNA (black lines) isolated from whole blood was 
sonicated. A 5-methylcytidine antibody was then added to the sonicated DNA, 
with the antibody (Ab) being bound to the methylated DNA (M). A secondary 
antibody (○), which was attached to magnetic beads (Dynabeads), was then 
bound to the primary antibody. Using a magnetic rack, the methylated DNA was 
separated from the unmethylated DNA. After a brief proteinase K digestion, the 
methylated DNA was purified. 
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(with 2 minutes “resting” intervals on ice between sonications), resulting in DNA 
fragments that were between 300-1000 base pairs in length.  After DNA purification, a 5-
methylcytidine mouse monoclonal antibody (Eurogentec) was added to the fragmented 
DNA and incubated overnight at 4○C with continuous shaking. A secondary antibody, 
Dynabeads M-280 sheep anti-mouse IgG (Invitrogen), was then added to the solution, 
which was incubated for 2 additional hours at 4○C.  The magnetic beads were then 
collected using a magnetic rack (Invitrogen). After removal of the supernatant, the DNA 
was washed three times in a 1x IP buffer solution (Mohn et al., 2009), and then digested 
using proteinase K. The methylated DNA was then isolated by phenol:chloroform 
extraction.  
 
Array CGH 
To optimize this assay for the recognition of differences between identical co-
twins, two experimental approaches were performed, as shown in Figure 16.  In the first 
method, each individual’s methylated DNA was differentially labeled and cohybridized 
to that same individual’s sonicated genomic, or “input” DNA.  In the second 
experimental approach, the methylated DNA fragments from the identical co-twins were 
differentially labeled (one twin labeled with Cy3; one with Cy5) and then competitively 
co-hybridized to the array chip.  For both approaches, the array comparative genomic 
hybridization (CGH) technique was performed according to the manufacturer guidelines 
using a BAC array platform (over 5000 replicated BAC clones including 143 OMIM 
genes at 100 Kb resolution, subtelomeres at 250 Kb, and screening of genomic backbone 
at 565 Kb resolution.) (BlueGnome Ltd, Cambridge, UK). 
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Figure 16. Illustration of the two different methods used for 
array CGH. In experimental approach 1, the methylated DNA was 
hybridized to that same individual’s sonicated genomic DNA (S. 
Input). In experimental approach 2, the methylated DNA from twin 
1 was hybridized to the methylated DNA of their identical co-twin 
(twin 2).   
Option 1 Option 2 
Twin 1 Twin 1 Twin 1 Co-Twin (Twin 2)  
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Array analysis 
The arrays were scanned using a ScanArray Gx Plus scanner (Perkin Elmer). The 
images were analyzed using a proprietary software program that was developed by 
BlueGnome.  Differences in methylated DNA amounts present were identified if the log2 
ratio values exceeded 0.4 or were less than -0.4. 
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Results 
         
Intra-individual MeDIP DNA hybridized to sonicated genomic DNA 
The differential ratios of the methyl-enriched DNA compared to the sonicated 
whole genomic DNA within the 4 individuals studied resulted in a range of 26 to 103 
areas of divergence.  Overall, hypermethylated regions (ranging from 17 to 89 per 
individual) were detected more frequently than hypomethylated regions (ranging from 8 
to 14). A comparison of the specific genomic information gained from these assays 
showed 12 loci to be consistently altered in all of the 4 individuals, with an additional 11 
regions showing either consistent hypo- or hypermethylation in 3 of the 4 individuals 
(Table 8). While 17 of these common regions were consistently hypermethylated and 4 
were consistently hypomethylated, 2 regions were differentially methylated 
(hypermethylated in 2 individuals and hypomethylated in 2 individuals). Overall, the 
methylation pattern in each individual was more similar to their co-twin’s pattern than 
that of an unrelated individual (Table 9).  
When comparing the co-twins’ patterns, a total of 24 differences were observed 
between the co-twins of pair one, while a total of 22 differences were detected between 
the co-twins of pair two (Table 9).  However, the standard deviations of these 
experiments, which were calculated by comparing the fluorochrome intensity values 
present on the replicate [2 for non-coding regions and 3 for genes] BACs on the arrays, 
were larger than those typically used for diagnostic interpretation, thereby underscoring 
the need for replication of these results.  A list of the differentially methylated BAC 
clones and the genes involved are presented in Tables 10 and 11. 
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Co-twin comparison using MeDIP DNA (twin 1) hybridized with MeDIP DNA (twin 
2)  
The direct competitive hybridization of the methyl-enriched co-twins’ DNA onto 
the microarray resulted in the detection of no (zero) differences in patterns between the 
co-twins of pair one.  However, methylation differences were observed between the co-
twins of pair two in 34 chromosome regions (Figure 17 and 18). Unlike the previous 
method, the standard deviations for this experiment (0.05 and 0.1) were within the values 
deemed acceptable for diagnostic use (0.1 or less).  The genomic regions with differential 
methylation for the identical co-twins from pair 2 (40 BACs) included 142 protein coding 
genes, 10 processed transcripts, 3 RNA genes, and 14 pseudogenes (Table 12). 
  In this second experimental approach, one cannot clearly categorize the 
methylation change that occurred as hypo- or hypermethylation since a gain in twin 1 
could reflect a hypermethylation from the “normal” state in twin 2, or it could represent a 
normal level, with twin 2 having hypomethylation.  
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Table 8. Regions having consistent methylation changes (approach 1). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-58A11 1p36.2 1MB backbone PLEKHG5 
NOL9 
TAS1R1 
ZBTB48 
KLHL21 
 AL591866.1 AL591866.2 
RP5-1033K19 1p31.2 1MB backbone RPE65   AL139413.1 
AL139413.2 
RP11-290P14 1q44 1MB backbone EFCAB2 
KIF26B 
 U1 AL589763.1 
RP11-480A4 3p14.2 1MB backbone RP11-541C17.1   AC104164.2 
AC104164.1 
RP11-541C17.2 
RP11-16M12 3p12.3 1MB backbone*  AC108752.1   
RP11-374I17 3q26.31 1MB backbone NAALADL2  snoU13  
RP11-565F4 5q23.1 1MB backbone   AC119040.2  
RP11-420L4 5q35.1 1MB backbone DOCK2    
RP11-417B10 7p11.1 1MB backbone    RP11-368M16.3 
RP11-368M16.6 
RP11-368M16.2 
RP11-368M16.7 
RP11-368M16.4 
RP11-368M16.5 
RP11-368M16.8 
RP11-368M16.1 
AC0648621.1 
RP4-669I17 7q36.1 1MB backbone MLL3    
RP11-19G1 9p23 1MB backbone PTPRD    
RP13-438M3 10p11.21 1MB backbone     
RP11-357L5 10q22.1 1MB backbone CDH23    
RP11-125F14 11p11.2 Known disease 
region 
MADD 
MYBPC3 
SPI1 
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Table 8 (continued). Regions having consistent methylation changes (approach 1). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
 
RP11-176A16 
 
11q14.1 
 
1MB backbone 
  
AC103881.1 
AC062032.1 
  
RP11-75L1 12p13.31 1MB backbone CLEC2D 
CLECL1 
CD69 
KLRF1 
CLEC2B 
   
RP11-125G9 12p12.2 1MB backbone SLCO1C1    
RP11-420C17 12q14.1 1MB backbone     
RP11-449024 12q24.21 Known disease 
region 
    
RP11-321F20 13q21.33 1MB backbone     
RP11-65B9 16p11.1 1MB backbone     
RP11-463D17 18q12.3 1MB backbone*     
RP11-97N8 19p12 1MB backbone ZNF56 
ZNF90 
AC011477.4 
AC007204.1 
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Table 9. Differential Methylation Patterns Observed following inter-individual 
analysis 
Individual 
(age) 
# 
Hypermethylated 
regions 
# Hypomethylated 
regions 
# Differences with 
co-twin pattern 
 
#73 73 7 2 
#74 89 14 22 
#C51 17 9 11 
#C52 17 9 11 
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Table 10. Regions having differential methylation between co-twin pair 1 as assessed from a comparison of patterns from 
individual-based hybridizations (approach 1). 
 
BAC Chromosomal 
location 
Characterization Protein 
coding 
Processed 
transcript 
RNA gene Pseudogene 
RP11-24.23 8q24.23 1MB backbone     
RP11-145B4 Xp21.2 1MB backbone     
RP11-117D22 1p32.3 1MB backbone  AC119428.1 
AC119428.2 
  
RP11-293B7 1q25.3 1MB backbone RGL1    
RP11-389K20 2p16.3 1MB backbone  AC139712.4  AC0793041 
RP11-575H3 2p11.1 Proposed disease region   U6 AC018696.2 
AC018696.7 
AC018696.6 
AC0186964 
AC018696.1 
AC018696.3 
AC018696.5 
AC116050.1 
RP11-554O1 
RP11-120C2 
3p14.3 1MB backbone CACNA2D3 
DNAH12 
  AC092057.1 
RP11-45C13 4q35.2 1MB backbone MTNR1A 
FAT1 
   
RP11-323M9 5p15.33 Proposed disease region AC010443.2 
PLEKHG4B 
AC021087.1 
CCDC127 
SDHA 
PDCD6 
 
 Y_RNA  
RP11-494C5 5q33.2 1MB backbone GRIA1    
RP11-132E3 8q22.3 1MB backbone RIMS2 
AC107933.1 
   
RP11-328K22 10q22.3 1MB backbone KCNMA1 AL731575.1   
RP11-349I16 11q21 1MB backbone AMOTL1    
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Table 10 (continued). Regions having differential methylation between co-twin pair 1 as assessed from a comparison of 
patterns from individual-based hybridizations (approach 1). 
 
BAC Chromosomal 
location 
Characterization Protein 
coding 
Processed 
transcript 
RNA gene Pseudogene 
RP11-320N7 12p13.32 1MB backbone    AC007207.1 
RP11-480P7 12q21.33 1MB backbone     
RP11-38M15 13q11 1MB backbone RP11-
38M15.1 
AL391382.6 
AL391382.4 
 AL391382.9 
AL391382.5 
AL391382.2 
AL391382.12 
AL391382.3 
AL391382.1 
AL391382.11 
RP11-38M15.3 
RP11-38M15.2 
RP11-183G17 15q11.2 Proposed disease region     
RP11-353B9 15q21.2 1MB Backbone DTWD1 
C15orf33 
   
RP11-143C19 15q26.2 1MB backbone SPATA8 
 
 7SK  
RP11-342L3 16p13.3 Proposed disease region KCTD5 
PRSS27 
PRSS33 
PRSS21 
TCEB2 
SRRM2 
AC141586.1 
AC141586.2 
AC092117.3 
AC092117.1 
 
 
AC141586.3 SNORA3 
AC092117.2
AC092117.4 
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Table 10 (continued). Regions having differential methylation between co-twin pair 1 as assessed from a comparison of 
patterns from individual-based hybridizations (approach 1). 
 
BAC Chromosomal 
location 
Characterization Protein 
coding 
Processed 
transcript 
RNA gene Pseudogene 
RP11.394B2 16q22.1 1MB backbone IL34 
MTSS1L 
VAC14 
AC020763.2 
AC020763.1 
   
RP11-46H21 17p25.3 1MB backbone ZNF750 
B3GNTL1 
AC068584.1 
   
RP3-324O17 20q11.21 1MB backbone HM13 
ID1 
AL110115.3 
AL110115.1 
U6 AL110115.2 
RP1-128O17 20q12 1MB backbone     
RP11-124N4 Xq23 Known disease region DCX    
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Table 11. Regions having differential methylation between co-twin pair 2 as assessed from a comparison of patterns from 
individual-based hybridizations (approach 1). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-480A4 3p14.2 1MB backbone RP11-641C17.1   AC104164.2 
AC104164.1 
RP11-641C17.2 
RP11-239O20 4q31.22 1MB backbone SLC10A7    
RP11-191M7 5q33.1 1MB backbone     
RP11-349C2 8q24.3 1MB backbone ADCK5 
CPSF1 
AF205589.2 
VPS28 
CYHR1 
NFKBIL2 
KIFC2 
FOXH1 
LRRC24 
LRRC14 
PPP1R16A 
C8orf82 
GPT 
MFSD3 
RECQL4 
AC084125.1 
AC084125.2 has-mir-939 
has-mir-1234 
 
RP13-438M3 10p11.21 1MB backbone     
RP11-125F14 11p11.2 1MB backbone MADD 
MYBPC3 
SPI1 
   
RP11-321F20 13q21.33 1MB backbone     
RP11-45G12 17p11.2 1MB backbone     
RP13-60P5 Xp21.3 1MB backbone MAGEB18   RP13-60P5.1 
MAGEB6B 
RP5-914P14 
RP11-549H3 
Xq23 Known disease 
region 
PAK3 
CAPN6 
DCX 
 U6 AL031117.1 
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Table 11 (continued). Regions having differential methylation between co-twin pair 2 as assessed from a comparison of 
patterns from individual-based hybridizations (approach 1). 
 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-58A11 1p36.31 1MB backbone PLEKHG5 
NOL9 
TAS1R1 
ZBTB48 
KLHL21 
 AL591866.1 AL591866.2 
RP11-290P14 1q44 1MB backbone EFCAB2 
KIF26B 
 U1 AL589763.1 
RP11-387A1 2q31.1 Known disease 
region 
EVX2 
HOXD13 
HOXD12 
HOXD10 
HOXD11 
HOXD9 
HOXD3 
HOXD8 
HOXD4 
HOXD1 
AC009336.1 
AC009336.5 
AC009336.4 
AC009336.2 
has-mir-10b  
RP11-374I17 3q26.31  NAALADL2  snoU13 
AC119040.2 
 
RP11-565F4 5q23.1  PRR16  U4  
RP11-140L4 11p15.4 Proposed disease 
region 
MRGPRG 
MRGPRE 
AC109309.1 
C11orf36 
 AC109309.2 
AC109309.3 
RP11-179A16 11q14.1 1MB backbone     
RP11-75L1 12p13.31 1MB backbone CLEC2D 
CLECL1 
CD69 
KLRF1 
CLEC2B 
   
RP11-420C17 12q14.1 1MB backbone     
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Table 11 (continued). Regions having differential methylation between co-twin pair 2 as assessed from a comparison of 
patterns from individual-based hybridizations (approach 1). 
 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-38M15 13q11 1MB backbone RP11-38M15.1 AL391382.6 
AL391382.4 
U6 
AL391382.8 
AL391382.9 
AL391382.5 
AL391382.2 
AL391382.12 
AL391382.3 
AL391382.1 
AL391382.11 
RP11-38M15.3 
RP11-183G17 15q11.2 Proposed disease 
region 
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Figure 17. Whole genomic view from software analysis of MeDIP product from twin 1 
hybridized to the MeDIP product from twin 2 (pair 1) No (zero) differences were observed for 
the pattern of methylated DNA present in these identical co-twins (s.d.= 0.05).  
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Figure 18. Whole genomic view from software analysis of MeDIP product from twin 3 hybridized to the MeDIP 
product from twin 4 (pair 2). A total of 33 differences in DNA methylation patterns were observed between these 
identical co-twins, who were discordant for high/low frequencies of micronuclei. These differences are depicted as red or 
green lines parallel to the ideogram at the chromosomal location of the divergent DNA (s.d.= 0.1). 
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Table 12. Regions having differential methylation between co-twin pair 2 as assessed from the competitive hybridization 
experimental approach (approach 2). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-181G12 
RP5-832C2 
1p36.33 Known disease region PRKCZ 
C1orf86 
AL590822.1 
AL590822.3 
SKI 
ATAD3B 
ATAD3A 
C1orf70 
SSU72 
AL645728.1 
RP11-181G12.1 
AL590822.2 
AL590822.4 
 AL645728.3 
RP11-9O10 2p12 1MB backbone     
RP11-118M12 2q37.3 1MB backbone AQP12B 
AC011298.2 
AC011298.3 
AC011298.1 
AQP12A 
KIF1A 
   
RP11-124522 4p16.3 1MB backbone     
RP11-180A12 4p16.1 1MB backbone AC105916.1    
RP11-43F13 5p15.33 Known disease region AC116351.2 
NKD2 
SLC12A7 
AC116351.1 
AC116351.5 
 AC1163513 AC1163514 
RP11-138M1 5q13.2 Known polymorphic 
region 
AC140134.2 
AC138866.1 
   
RP4-800G7 
RP4-669I17 
7q36.1 1MB backbone MLL3    
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Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive 
hybridization experimental approach (approach 2). 
 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-248K13 
RP11-52B19 
8p23.3 High GC content region AC105233.6 
FAM90A11 
AC105233.4 
AC105233.2 
AC105233.3 
AC105233.5 
FAM90A24P 
 hsa-mir-
548i-3 
AC105233.1 
RP11-417A4 9q34.3 1MB backbone PNPLA7 
MRPL41 
WDR85 
ZMYND19 
ARRDC1 
C9orf37 
EHMT1 
  AL590627.1 
RP13-244L6 10q11.21 Known disease region CSGALNACT2 
RASGEF1A 
AC068707.3   
RP11-357L5 10q22.1 1MB backbone CDH23    
RP13-449N13 10q26.3 1MB backbone STK32C    
RP11-2B17 11p15.5 1MB backbone     
RP11-58D3 11p13.1 1MB backbone KAT5 
RNASEH2C 
OVOL1 
SNX32 
CFL1 
MUS81 
  AP001266.2 
AP001266.2 
RP11-119D9 11q13.2 Known disease region AP003716.2 
AP003716.1 
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Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive 
hybridization experimental approach (approach 2). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-567M21 11q24.3 1MB backbone PRDM10 
NCRNA00167 
AP003041.3 
APLP2 
 U4 AP003041.4 
AP003041.1 
RP11-429N9 12p21.32 1MB backbone C12orf50 
C12orf9 
CEP290 
  AC090060.1 
RP11-449O24 12q24.21 Known disease region     
RP11-503G7 12q24.33 1MB backbone AC148477.3 
MUC8 
FBRSL1 
   
RP3-514A23 14q24.2 1MB backbone RGS6 
DPF3 
   
RP11-358F6 16p13.3 High GC content region SOX8 
SSTR5 
C1QTNF8 
AC009041.3 
AC009041.7 
AC009041.1 
AC009041.6 
AC009041.8 
AC009041.4 
AC009041.5 
AL031713.1 
  AC009041.2 
RP11-288I13 16p12.3 1MB backbone XYLT1    
RP11-278A23 16q24.2 1MB backbone JPH3 
KLHDC4 
AC010536.1 
AC010536.2 
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Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive 
hybridization experimental approach (approach 2). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-368I7 
RP11-533D19 
16q24.3 1MB backbone CPNE7 
DPEP1 
CHMP1A 
C16orf55 
CDK10 
SPATA2L 
C16orf7 
ZNF276 
AC010538.1 
SPIRE2 
TCF25 
TUBB3 
DEF8 
GAS8 
DBNDD1 
AC092143.1 
AC092143.3 
C16orf3 
AC133919.7 
AFG3L1   
RP11-475F12 
RP11-45506 
17q25.3 Proposed disease region FASN 
CCDC57 
SLC16A3 
CSNK1D 
AC132872.4 
  AC132872.2 
RP11-100K18 
RP11-315M18 
18q23 1MB backbone AC068473.1    
RP11-330I7 19p13.3 1MB backbone CD70 
C3 
TNFSF14 
TRIP10 
GPR108 
  AC008760.1 
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Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive 
hybridization experimental approach (approach 2). 
BAC Chromosomal 
location 
Characterization Protein coding Processed 
transcript 
RNA gene Pseudogene 
RP11-9B17 19p13.2 1MB backbone ZNF781 
ZNF607 
ZNF573 
AC093227.1 
   
RP11-353C18 20q11.22 1MB backbone NFS1 
ROMO1 
RBM39 
AL357374.3 
PHF20 
  BXDC1P 
RP11-93B14 20q13.33 Proposed disease region RP11-93B14.1 
SLCO4A1 
C20orf90 
NTSR1 
 
RP11-93B14.2 
AL357033.1 
  
RP11-135B17 21q22.3 1MB backbone DIP2A 
S100B 
PRMT2 
  AP000339.1 
RP5-1119A7 22q12.3 1MB backbone TXN2 
FOXRED2 
EIF3D 
RP5-1119A7.1 
CACNG2 
CR383704.1 
AL022313.1 
  
RP11-164E23 22q13.33 Known disease region SAPS2 
SBF1 
ADM2 
MIOX 
LMF2 
NCAPH2 
SCO2 
TYMP 
ODF3B 
KLHDC7B 
U62317.1   
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Discussion 
 
To achieve the primary goal of this study, the methylation profiles of 2 
monozygotic twin pairs were compared using two different experimental approaches.  
For this preliminary assessment, these particular twin pairs were selected on the basis of: 
(1) their age (we selected older twins since it has been hypothesized that methylation 
changes accumulate with age); and (2) micronuclei frequencies (the co-twins from one 
pair had very similar micronuclei frequencies, while the co-twins from the other pair 
presented with significantly different micronuclei frequencies).   
Each of the two whole genome experimental approaches used in this pilot study 
had apparent strengths and weaknesses.  A strength of the first technique (Approach 1) 
was that it enabled one to directly assess if the observed changes in patterns resulted from 
hypermethylation or hypomethylation. Of interest was the observation of 23 consistent 
regions, for methylation, that were present between the study participants. Some common 
areas are expected since the sample DNA was isolated from the same tissue type (white 
blood cells).  Interestingly, the standard deviations associated with these experiments 
exceeded those typically obtained from conventional genomic hybridization experiments. 
The cause for this increase is not clear, with additional experiments being required to 
discern if this finding reflects a consistent problem associated with the methodological 
approach.  Despite the increased standard deviation values seen (which makes the 
detection of differences more difficult), variation in the identified regions was detected 
between the identical co-twins. However, the total number of differences between pairs 
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was very similar, with slightly more divergence being observed for the pair having the 
least difference in micronuclei frequencies and exposures.  
In the second technique (approach 2), the methyl-enriched DNA from the 
identical co-twins were directly compared.  As noted in the results, a shortcoming of this 
experimental approach is that one cannot directly classify the recognized alterations as 
being attributable to hyper- versus hypo-methylation, since the observed values are in 
relation to those seen in the methyl enriched portion of the co-twin’s DNA rather than to 
the overall genome.  However, a benefit of this method is that it is more cost effective 
(reduces cost by half ) and may be more sensitive for detecting differences between co-
twins, since it led to the recognition of  33 differences between the co-twins of pair 2 [but 
fewer (zero) differences in the co-twins of pair one].  Also, since the methyl-enriched 
DNAs that are co-hybridized in these experiments were collected using identical 
procedures, the standard deviations of this experiment were lower, falling within the 
clinically acceptable range.   
When comparing the types of regions identified using each of the two techniques, 
it appears that approach 1 identified more RNA genes and pseudogenes, while approach 2 
identified more protein coding regions.   The biological relevance of this observation is 
unclear and warrants further evaluation using a second confirmatory approach (such as 
bisulfite sequencing methodology). 
In summary, while the sample size used for this pilot study was small, the results 
support the hypothesis that changes in the global methylation profiles were present 
between these identical twins, who were 69 and 85 years old.  Excitingly, based on 
approach two, these changes appear to be more prevalent in people having more diversity 
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for environmental/health histories, as well as biomarker (micronuclei) divergence. Our 
future studies, in which we will study epigenome patterns between identical co-twins 
ranging in age from 7 to 85, should enable us to determine at what age monozygotic 
twins begin to diverge epigenetically, if specific environmental exposures influence this 
divergence, and if this phenomenon can be consistently correlated with genetic indicators 
of aging, such as aneuploidy or micronuclei frequencies.   
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Chapter 6. 
 
Conclusions 
 
A. To determine the influence that genetic and/or environmental factors have on the 
frequency of spontaneously occurring micronuclei in children and adults, cells from 
identical and fraternal twins were evaluated. These studies led to the following primary 
conclusions: 
 
1. No significant difference in micronuclei frequencies was seen for males (1.39% ± 
0.11%) compared to females (1.22% ± 0.10%) (p=0.87). 
 
2. Micronuclei frequencies significantly increased with age (p<0.0001, r=0.446), ranging 
from a low of  0.56%  0.11%  in 7-9 year-olds, to a high of  2.25%  0.25% in 60-69 
year-olds.   
 
3. Although monozygotic twins (r=0.5, p=0.003) had a higher correlation coefficient than 
dizygotic twins (r=0.42, p=0.118), these values indicated a contribution of environmental 
factors. Model fitting, implemented in Mx, showed the best fit for the data to result from 
contributions due to either additive genetic and unique environment or common and 
unique environmental factors.  
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4. Environmental exposures and health conditions that showed a significantly increased 
frequency of micronuclei included a history of allergies (p=0.00019), and consumption of 
vitamin E supplements (p=0.0251). In contrast, significantly lower micronuclei 
frequencies were associated with eating fruit (p=0.0162), eating leafy green vegetables 
(p= 0.0007), having a history of arthritis (p=0.0005), and having a history of heart disease 
(p=0.0381). However, this latter effect may be confounded by medication usage since 
ACE inhibitors and diuretics were associated with significantly decreased (p=0.0132) or 
increased (p=0.0023) micronuclei frequencies, respectively.  
 
B. For a subset of twins having 5% or more micronuclei containing sex chromosomes, 
the number of sex chromosomes (and chromosome 17) present in the binucleates having 
one or more micronuclei was determined. These studies led to the following primary 
conclusions: 
 
1. In both genders, the frequency of micronuclei containing a sex chromosome was 
significantly higher than that observed for chromosome 17 (autosomal control). 
 
2. The probe signal patterns noted in the total of 1,017 binucleated cells having at least 
one micronucleus with a signal for chromosomes X, Y, or 17 included three primary 
types of binucleate cells: those having a hyperdiploid complement; a hypodiploid 
complement; or a euploid complement, the latter of which had an apparent chromosomal 
imbalance that was “corrected” through its exclusion into the micronucleus (trisomy 
rescue).   
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3. In the males, the percentage of cells having a euploid binucleate with a “corrected” 
micronuclear pattern for the Y chromosome was significantly higher in the younger 
subjects (p=0.026), while those having a hypodiploid binucleate pattern tended to 
increase with age.      
 
4. In the females, the percentage of cells having a euploid binucleate with a “corrected” 
micronuclear pattern for the X chromosome was significantly higher in the younger 
subjects (p=0.030), while those having a hypodiploid binucleate pattern tended to 
increase with age.      
 
5. No significant age-related difference in the proportion of hyperdiploid binucleates was 
observed for the X (males or females) or Y chromosome (males).   
 
C. The chromosomal contents of micronuclei were determined using Spectral 
Karyotyping (SKY) methodology. These age-related influences on chromosome-specific 
frequencies of micronuclei were also evaluated. These studies led to the following 
primary conclusions: 
 
 
1. The majority of micronuclei (89.6%) contained chromatin from a single chromosome. 
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2. All 24 chromosomes were observed to be present in at least 5 micronuclei. However, 
the chromosome-specific frequencies varied, with the sex chromosomes being observed 
most frequently in the micronuclei evaluated from both males and females (p<0.0001). 
 
3. Of the autosomes, chromosomes 4, 8, and 9 were found with a significantly higher 
frequency than expected by chance, while chromosomes 17 and 22 were found much less 
frequently than expected (p<0.0001).  
 
4.  No difference was observed in the pattern of autosomes present in the micronuclei 
studied from males compared to females (p=0.7). 
 
5.  There was no significant difference in the pattern of autosomal chromatin exclusion 
into micronuclei between adults (ages 25-81) and children (ages 7-19 years) (p=0.9). 
 
6.  A positive correlation was detected for the proportion of X chromatin-containing 
micronuclei in females with age (p<0.0001) and for the Y chromosome in males with age 
(p<0.0001). 
 
7. The ability of the SKY software to accurately detect the chromosomal contents of a 
micronucleus was determined to be between 83% (when using centromeric probes) and 
89% (when using painting probes). The discrepancy in this value suggests that some of 
the micronuclei may contain chromosomal fragments.   
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D. Global methylation profiles were determined (using a MeDIP Chip) for two 
monozygotic twin pairs by isolating methyl-enriched DNA and hybridizing it to either the 
co-twins methyl-enriched DNA or to the individual’s sonicated total DNA (methylated 
and non-methylated). These studies led to the following primary conclusions: 
 
1.  Overall, hypermethylated regions (ranging from 17 to 89 per individual) were detected 
more frequently than hypomethylated regions (ranging from 8 to 14). 
 
2. A comparison of the specific genomic information gained from hybridizing an 
individual’s methyl-enriched DNA to their sonicated total DNA showed 12 loci to be 
consistently altered in all of the 4 individuals, with an additional 11 regions showing 
either consistent hypo- or hypermethylation in 3 of the 4 individuals. 
 
3. Through direct competitive hybridization of the co-twins’ methyl-enriched DNA onto 
a genome-wide microarray, an increased frequency of methylation differences was 
observed between the co-twins having different micronuclei frequencies and 
environmental exposures (33 differences) when compared to the divergence observed 
between the co-twin’s having similar micronuclei frequencies and environmental 
exposures (0 methylation differences). This finding suggests there may be a link between 
acquired chromosomal instability and epigenetic changes.  
 
     In summary, genetic and epigenetic changes, as assessed through micronuclei and 
methylation, do occur with age and these acquired abnormalities appear to be complex 
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traits that are influenced by unique environmental factors as well as other factors (such as 
additive genetic or common environmental effects).  We are the first to have discovered 
an in vivo link between blood pressure medications and micronuclei frequencies. We 
have also performed the most comprehensive study to date examining the chromosomal 
contents of micronuclei.  In addition, we are the first to propose the possible “corrective” 
function of micronuclei.  It is anticipated that the baseline micronuclei data we presented 
in this study will help future researchers develop preventative care, screening tests, and 
therapies for the various health conditions associated with micronuclei.  
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